Gene Symbol	Name	Entrez GeneId	Genome Location	Tier	Hallmark	Chr Band	Somatic	Germline	Tumour Types(Somatic)	Tumour Types(Germline)	Cancer Syndrome	Tissue Type	Molecular Genetics	Role in Cancer	Mutation Types	Translocation Partner	Other Germline Mut	Other Syndrome	Synonyms
A1CF	APOBEC1 complementation factor	29974.0	10:50799421-50885675	2		10q11.23	yes		melanoma			E		oncogene	Mis				ACF,ACF64,ACF65,APOBEC1CF,ASP,CCDS73133.1,ENSG00000148584.14,NM_001198819.1,NP_001185748
ABL1	v-abl Abelson murine leukemia viral oncogene homolog 1	25.0	9:130713946-130885683	1	Yes	9q34.12	yes		CML, ALL, T-ALL			L	Dom	oncogene, fusion	T, Mis	BCR, ETV6, NUP214			ABL,CCDS35165.1,ENSG00000097007.17,JTK7,NM_007313.2,NP_009297,P00519,c-ABL,p150
ABL2	c-abl oncogene 2, non-receptor tyrosine kinase	27.0	1:179099327-179229601	1		1q25.2	yes		AML			L	Dom	oncogene, fusion	T	ETV6			ABLL,ARG,CCDS30947.1,ENSG00000143322.19,NM_007314.3,NP_009298,P42684
ACKR3	atypical chemokine receptor 3	57007.0	2:236569641-236582358	1	Yes	2q37.3	yes		lipoma			M	Dom	oncogene, fusion	T	HMGA2			CCDS2516.1,CMKOR1,CXCR7,ENSG00000144476.5,GPR159,NM_020311.2,NP_064707,P25106,RDC1
ACVR1	activin A receptor, type I	90.0	2:157736444-157875111	1	Yes	2q24.1	yes		DIPG			O	Dom	oncogene	Mis		yes	Fibrodysplasia ossificans progressiva	ACVR1A,ACVRLK2,ALK2,CCDS2206.1,ENSG00000115170.13,NM_001347666.1,NP_001096,NP_001334595.1,NP_001334594.1,NP_001334592.1,Q04771,SKR1
AFDN	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)	4301.0	6:167827635-167970232	1		6q27	yes		AL			L	Dom	oncogene, fusion	T	KMT2A			AF-6,AF6,CCDS78199.1,ENSG00000130396.20,MLLT4,NM_001291964.1,NP_001278893
AFF3	AF4/FMR2 family, member 3	3899.0	2:99551121-100106128	1	Yes	2q11.2	yes		ALL, T-ALL			L	Dom	oncogene, fusion	T	KMT2A, RUNX1			CCDS33258.1,ENSG00000144218.18,LAF4,MLLT2-like,NM_001025108.1,NP_001020279,P51826
AFF4	AF4/FMR2 family, member 4	27125.0	5:132875379-132963634	1	Yes	5q31.1	yes		ALL			L	Dom	oncogene, fusion	T	KMT2A			AF5Q31,CCDS4164.1,ENSG00000072364.12,MCEF,NM_014423.3,NP_055238,Q9UHB7
AKT1	v-akt murine thymoma viral oncogene homolog 1	207.0	14:104769349-104794124	1	Yes	14q32.33	yes		breast, colorectal, ovarian, NSCLC			E	Dom	oncogene	Mis				AKT,CCDS9994.1,ENSG00000142208.15,P31749,PKB,PRKBA,RAC
AKT2	v-akt murine thymoma viral oncogene homolog 2	208.0	19:40230317-40285395	1		19q13.2	yes		ovarian, pancreatic			E	Dom	oncogene	A				CCDS12552.1,ENSG00000105221.16,NM_001626.5,NP_001617,P31751
AKT3	v-akt murine thymoma viral oncogene homolog 3	10000.0	1:243499720-243843282	2		1q44	yes		GBM			O		oncogene	A				CCDS31077.1,ENSG00000117020.16,NM_005465.4,NP_005456,PKBG,PRKBG,Q9Y243,RAC-gamma
ALK	anaplastic lymphoma kinase (Ki-1)	238.0	2:29192774-29921566	1	Yes	2p23.2	yes	yes	ALCL, NSCLC, neuroblastoma, inflammatory myofibroblastic tumour, Spitzoid tumour	neuroblastoma	familial neuroblastoma	L, E, M	Dom	oncogene, fusion	T, Mis, A	NPM1, TPM3, TFG, TPM4, ATIC, CLTC, MSN, RNF213, CARS, EML4, KIF5B, C2orf22, DCTN1, HIP1, TPR, RANBP2, PPFIBP1, SEC31A, STRN, VCL, C2orf44, KLC1			CCDS33172.1,CD246,ENSG00000171094.17,NM_004304.4,NP_004295,Q9UM73
APOBEC3B	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	9582.0	22:38982409-38992784	1	Yes	22q13.1		yes		breast cancer		E	Rec	oncogene, TSG	D				CCDS13982.1,ENSG00000179750.15,FLJ21201,NM_004900.4,NP_004891,NP_004891.4,PHRBNL,Q9UH17
AR	Androgen Receptor	367.0	X:67544036-67730619	1	Yes	Xq12	yes	yes	prostate			E	Dom	oncogene	Mis		yes	Androgen insensitivity, Hypospadias 1, X-linked, Spinal and bulbar muscular atrophy of Kennedy	AIS,CCDS14387.1,DHTR,ENSG00000169083.16,HUMARA,NM_000044.3,NP_000035,NR3C4,P10275,SBMA,SMAX1
ARAF	A-Raf proto-oncogene, serine/threonine kinase	369.0	X:47561100-47571920	2		Xp11.3	yes		cholangiocarcinoma, lung adenocarcinoma, Langerhans cell histiocytosis			E, L		oncogene	Mis				ARAF1,CCDS75970.1,ENSG00000078061.12,NM_001256196.1,NP_001243125
ARHGAP5	Rho GTPase activating protein 5	394.0	14:32077289-32159728	2		14q12	yes		colon cancer, glioma			E, O		oncogene	Mis				CCDS32062.1,ENSG00000100852.12,GFI2,NM_001030055.1,NP_001025226,Q13017,RhoGAP5,p190-B,p190BRhoGAP
ARNT	aryl hydrocarbon receptor nuclear translocator	405.0	1:150809705-150876768	1	Yes	1q21.3	yes		AML			L	Dom	oncogene, TSG, fusion	T	ETV6			CCDS970.1,ENSG00000143437.20,HIF-1beta,NM_001668.3,NP_001659,NP_001337154.1,NP_001337155.1,NP_001337153.1,P27540,bHLHe2
ATF1	activating transcription factor 1	466.0	12:50764292-50821122	1	Yes	12q13.12	yes		malignant melanoma of soft parts, angiomatoid fibrous histiocytoma			E, M	Dom	oncogene, fusion	T	EWSR1, FUS			CCDS8803.1,ENSG00000123268.8,NM_005171.4,NP_005162,P18846,TREB36
ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	476.0	1:116373867-116404772	1	Yes	1p13.1	yes		adrenal aldosterone producing adenoma			E	Dom	oncogene, TSG	Mis, O				CCDS53351.1,ENSG00000163399.15,NM_001160233.1,NP_001153705,P05023
BCL11A	B-cell CLL/lymphoma 11A	53335.0	2:60457192-60555154	1	Yes	2p16.1	yes		B-CLL			L	Dom	oncogene, fusion	T	IGH			BCL11A-L,BCL11A-S,BCL11A-XL,CCDS1862.1,CTIP1,ENSG00000119866.21,EVI9,HBFQTL5,NM_022893.3,NP_075044,ZNF856
BCL11B	B-cell CLL/lymphoma 11B  (CTIP2)	64919.0	14:99169287-99271228	1	Yes	14q32.2	yes		T-ALL			L	Dom	oncogene, TSG, fusion	T	TLX3			CCDS9950.1,CTIP-2,CTIP2,ENSG00000127152.17,NM_138576.3,NP_612808,NP_001269166.1,Q9C0K0,ZNF856B,hRIT1-alpha
BCL2	B-cell CLL/lymphoma 2	596.0	18:63123346-63320128	1		18q21.33	yes		NHL, CLL			L	Dom	oncogene, fusion	T	IGH			Bcl-2,CCDS11981.1,ENSG00000171791.12,NM_000633.2,NP_000624,P10415,PPP1R50
BCL2L12	BCL2 like 12	83596.0	19:49665142-49673915	2		19q13.33	yes		melanoma, SCC			E		oncogene	Mis				CCDS12776.1,ENSG00000126453.9,NM_138639.1,NP_619580,Q9HB09
BCL3	B-cell CLL/lymphoma 3	602.0	19:44748547-44760044	1		19q13.32	yes		CLL			L	Dom	oncogene, fusion	T	IGH			BCL4,CCDS12642.2,D19S37,ENSG00000069399.14,NM_005178.4,NP_005169,P20749
BCL6	B-cell CLL/lymphoma 6	604.0	3:187721377-187745727	1		3q27.3	yes		NHL, CLL			L	Dom	oncogene, fusion	T, Mis	IG loci, ZNFN1A1, LCP1, PIM1, TFRC, CIITA, NACA, HSPCB, HSP90AA1, HIST1H4I, IL21R,  POU2AF1, RHOH, EIF4A2, SRSF3			BCL5,BCL6A,CCDS3289.1,ENSG00000113916.17,LAZ3,NM_001706.4,NP_001697,P41182,ZBTB27,ZNF51
BCL9	B-cell CLL/lymphoma 9	607.0	1:147541412-147626216	1	Yes	1q21.2	yes		B-ALL			L	Dom	oncogene, fusion	T	IGH, IGL			CCDS30833.1,ENSG00000116128.10,NM_004326.3,NP_004317,O00512
BCL9L	B-cell CLL/lymphoma 9-like	283149.0	11:118893875-118910904	1	Yes	11q23.3	yes		colorectal cancer, endometrial carcinoma, gastric cancer			E		oncogene, TSG	Mis, F				CCDS8403.1,DLNB11,ENSG00000186174.12,NM_182557.2,NP_872363,Q86UU0
BCORL1	BCL6 corepressor-like 1	63035.0	X:130005188-130058083	1	Yes	Xq26.1	yes		AML, HNSCC			E, L		oncogene, TSG	Mis, N, F				CCDS14616.1,CXorf10,ENSG00000085185.15,FLJ11362,NM_021946.4,NP_068765,NP_001171701.1,Q5H9F3
BIRC3	baculoviral IAP repeat-containing 3	330.0	11:102317495-102337734	1	Yes	11q22.2	yes		CLL, MALT, MCL, MM			L	Dom	oncogene, TSG, fusion	D, F, N, T, Mis	MALT1			API2,CCDS8315.1,ENSG00000023445.13,MALT2,MIHC,Q13489,RNF49,c-IAP2,cIAP2,hiap-1
BIRC6	baculoviral IAP repeat containing 6	57448.0	2:32357028-32618899	2		2p22.3	yes		melanoma, gastric adenocarcinoma, lung adenocarcinoma			E		oncogene, fusion	T, Mis	ALK			BRUCE,CCDS33175.2,ENSG00000115760.13,NM_016252.3,NP_057336,Q9NR09
BMPR1A	bone morphogenetic protein receptor, type IA	657.0	10:86756650-86932838	1	Yes	10q23.2		yes		gastrointestinal polyps	juvenile polyposis	E	Rec	oncogene, TSG	Mis, N, F				ACVRLK3,ALK3,CCDS7378.1,CD292,ENSG00000107779.13,NM_004329.2,NP_004320,P36894
BRAF	v-raf murine sarcoma viral oncogene homolog B1	673.0	7:140730665-140924928	1	Yes	7q34	yes		melanoma, colorectal, papillary thyroid, borderline ovarian, NSCLC, cholangiocarcinoma, pilocytic astrocytoma, Spitzoid tumour, pancreas acinar carcinoma, melanocytic nevus, prostate, gastric			E, O	Dom	oncogene, fusion	Mis, T, O	AKAP9, KIAA1549, CEP88, LSM14A, SND1, FCHSD1, SLC45A3, FAM131B, RNF130, CLCN6, MKRN1, GNAI1, AGTRAP	yes	Cardio-facio-cutaneous syndrome	BRAF1,CCDS5863.1,ENSG00000157764.13,NM_004333.4,NP_004324
BRD3	bromodomain containing 3	8019.0	9:134030305-134068017	1		9q34.2	yes		lethal midline carcinoma of young people			E	Dom	oncogene, fusion	T	NUTM1			CCDS6980.1,ENSG00000169925.16,KIAA0043,NM_007371.3,NP_031397,ORFX,Q15059,RING3L
BRD4	bromodomain containing 4	23476.0	19:15235519-15280451	1	Yes	19p13.12	yes		lethal midline carcinoma of young people			E	Dom	oncogene, fusion	T	NUTM1			CAP,CCDS12328.1,ENSG00000141867.17,HUNK1,HUNKI,MCAP,NM_058243.2,NP_490597,O60885
BTK	Bruton agammaglobulinemia tyrosine kinase	695.0	X:101349447-101390796	1	Yes	Xq22.1	yes		CLL, mantle cell lymphoma, WM			L	Dom	oncogene, TSG	Mis		yes	agammaglobulinemia	AGMX1,ATK,CCDS76003.1,ENSG00000010671.15,IMD1,NM_001287344.1,NP_001274273,PSCTK1,Q06187,XLA
CACNA1D	calcium channel, voltage-dependent, L type, alpha 1D subunit	776.0	3:53495049-53813733	1	Yes	3p21.1	yes		adrenal aldosterone producing adenoma			E	Dom	oncogene	Mis		yes	Syndrome featuring primary aldosteronism, seizures and neuromuscular disease.	CACH3,CACN4,CACNL1A2,CCDS2872.1,CCHL1A2,Cav1.3,ENSG00000157388.16,Q01668
CALR	calreticulin	811.0	19:12938607-12944489	1	Yes	19p13.13	yes		MPN, MDS			L	Dom	oncogene	F, Mis				CCDS12288.1,CRT,ENSG00000179218.13,FLJ26680,NM_004343.3,NP_004334,P27797,RO,SSA,cC1qR
CARD11	caspase recruitment domain family, member 11	84433.0	7:2906141-3043945	1	Yes	7p22.2	yes		DLBCL			L	Dom	oncogene	Mis				BIMP3,CARMA1,CCDS5336.2,ENSG00000198286.9,NM_032415.5,NP_001311210,NP_115791,Q9BXL7
CBL	Cas-Br-M (murine) ecotropic retroviral transforming	867.0	11:119206276-119308149	1	Yes	11q23.3	yes		AML, JMML, MDS			L	Dom/Rec	oncogene, TSG, fusion	T, Mis, S, O	KMT2A			CBL2,CCDS8418.1,ENSG00000110395.6,NM_005188.3,NP_005179,P22681,RNF55,c-Cbl
CBLC	Cas-Br-M (murine) ecotropic retroviral transforming sequence c	23624.0	19:44777869-44800634	1		19q13.32	yes		AML			L	Rec	oncogene, TSG	Mis				CBL-3,CBL-SL,CCDS12643.1,ENSG00000142273.11,NM_012116.3,NP_036248,Q9ULV8,RNF57
CCND1	cyclin D1	595.0	11:69641087-69654474	1	Yes	11q13.3	yes		CLL, B-ALL, breast			L, E	Dom	oncogene, fusion	T	IGH, FSTL3			BCL1,CCDS8191.1,D11S287E,ENSG00000110092.3,NM_053056.2,NP_444284,P24385,PRAD1,U21B31
CCND2	cyclin D2	894.0	12:4273772-4305350	1	Yes	12p13.32	yes		NHL,CLL			L	Dom	oncogene, fusion	T	IGL			CCDS8524.1,ENSG00000118971.7,NM_001759.3,NP_001750,P30279
CCND3	cyclin D3	896.0	6:41934933-41941848	1		6p21.1	yes		MM			L	Dom	oncogene, fusion	T	IGH			CCDS4863.1,ENSG00000112576.12,NM_001760.4,NP_001751,P30281
CCNE1	cyclin E1	898.0	19:29811898-29824308	1	Yes	19q12	yes		serous ovarian			E	Dom	oncogene	A				CCDS12419.1,CCNE,ENSG00000105173.13,NM_001322261.1,NP_001229,NP_001309190.1,NP_001309188.1,P24864
CCR4	C-C motif chemokine receptor 4	1233.0	3:32951574-32956349	2		3p22.3	yes		adult T-cell leukaemia/lymphoma			L		oncogene	N				CC-CKR-4,CCDS2656.1,CD194,CKR4,CMKBR4,ChemR13,ENSG00000183813.6,NM_005508.4,NP_005499,P51679,k5-5
CCR7	C-C motif chemokine receptor 7	1236.0	17:40553769-40565472	2		17q21.2	yes		adult T-cell leukaemia/lymphoma			L		oncogene	N				BLR2,CCDS11369.1,CD197,CDw197,CMKBR7,EBI1,ENSG00000126353.3,NM_001838.3,NP_001829,P32248
CD28	CD28 molecule	940.0	2:203706548-203738912	2		2q33.2	yes		T-cell lymphoma			L		oncogene	Mis				CCDS2361.1,ENSG00000178562.17,NM_006139.3,NP_006130,NP_001230006.1,P10747
CD74	CD74 molecule, major histocompatibility complex, class II invariant chain	972.0	5:150402152-150412751	1		5q33.1	yes		NSCLC			E	Dom	oncogene, fusion	T	ROS1, NRG1			CCDS47309.1,DHLAG,ENSG00000019582.14,NM_001025159.2,NP_001020330,P04233
CD79A	CD79a molecule, immunoglobulin-associated alpha	973.0	19:41877120-41881372	1	Yes	19q13.2	yes		DLBCL, WM			L	Dom	oncogene	S		yes	Agammaglobulinaemia	CCDS12589.1,ENSG00000105369.9,IGA,MB-1,NM_001783.3,NP_001774,P11912
CD79B	CD79b molecule, immunoglobulin-associated beta	974.0	17:63928740-63932336	1	Yes	17q23.3	yes		DLBCL, WM			L	Dom	oncogene	Mis, S		yes	Agammaglobulinaemia	B29,CCDS42372.1,ENSG00000007312.12,IGB,NM_001039933.1,NP_001035022,P40259
CDH17	cadherin 17	1015.0	8:94127171-94208587	2		8q22.1	yes		melanoma			E		oncogene	Mis				CCDS6260.1,ENSG00000079112.9,HPT-1,NM_004063.3,NP_004054,Q12864,cadherin
CDK4	cyclin-dependent kinase 4	1019.0	12:57747727-57752521	1	Yes	12q14.1		yes		melanoma	familial malignant melanoma	E	Dom	oncogene	Mis				CCDS8953.1,ENSG00000135446.16,NM_000075.3,NP_000066,P11802,PSK-J3
CDK6	cyclin-dependent kinase 6	1021.0	7:92604921-92833917	1	Yes	7q21.2	yes		ALL			L	Dom	oncogene, fusion	T	MLLT10			CCDS5628.1,ENSG00000105810.9,NM_001259.6,NP_001250,PLSTIRE,Q00534
CDKN1A	cyclin dependent kinase inhibitor 1A	1026.0	6:36678710-36687337	2		6p21.2	yes		bladder cancer			E		oncogene, TSG	F, N				CAP20,CCDS4824.1,CDKN1,CIP1,ENSG00000124762.13,NM_001220778.1,NP_001207707,P21,P38936,SDI1,WAF1,p21,p21CIP1,p21Cip1/Waf1
CHD4	chromodomain helicase DNA binding protein 4	1108.0	12:6570088-6607476	1	Yes	12p13.31	yes		uterine serous carcinoma			E	Dom	oncogene	Mis, F, N				CCDS8552.1,ENSG00000111642.15,Mi-2b,Mi2-BETA,NM_001273.3,NP_001264
CHST11	carbohydrate sulfotransferase 11	50515.0	12:104456973-104762014	2		12q23.3	yes		B-CLL			L		oncogene, fusion	T				C4ST,C4ST1,C4St-1,CCDS9099.1,ENSG00000171310.10,HSA269537,NM_018413.5,NP_060883,Q9NPF2
CIC	capicua homolog	23152.0	19:42284665-42295797	1	Yes	19q13.2	yes		oligodendroglioma, soft tissue sarcoma			O, M	Rec	oncogene, TSG, fusion	Mis, F, S,T	DUX4L1, FOXO4			CCDS12601.1,ENSG00000079432.7,KIAA0306,NM_015125.4,NP_055940,Q96RK0
CREB1	cAMP responsive element binding protein 1	1385.0	2:207529892-207603431	1		2q33.3	yes		clear cell sarcoma, angiomatoid fibrous histiocytoma			M	Dom	oncogene, fusion	T	EWSR1			CCDS2375.1,ENSG00000118260.14,NM_134442.4,NP_604391,P16220
CREB3L2	cAMP responsive element binding protein 3-like 2	64764.0	7:137874979-138002057	1	Yes	7q33	yes		fibromyxoid sarcoma			M	Dom	oncogene, fusion	T	FUS			BBF2H7,CCDS34760.1,ENSG00000182158.14,NM_194071.3,NP_919047,NP_001305175.1,Q70SY1,TCAG_1951439
CREBBP	CREB binding protein (CBP)	1387.0	16:3725054-3880726	1	Yes	16p13.3	yes		ALL, AML, DLBCL, B-NHL			L	Dom/Rec	oncogene, TSG, fusion	T, N, F, Mis, O	KMT2A, MORF, KAT6A	yes	Rubinstein-Taybi syndrome	CBP,CCDS10509.1,ENSG00000005339.14,KAT3A,NM_004380.2,NP_004371,Q92793,RSTS,RTS
CRLF2	cytokine receptor-like factor 2	64109.0	X:1190490-1212750	1	Yes	Xp22.33	yes		B-ALL, Downs associated ALL			L	Dom	oncogene, fusion	Mis, T	P2RY8, IGH			CCDS75945.1,CRL2,ENSG00000205755.11,NM_022148.3,NP_071431,Q9HC73,TSLPR
CRTC1	CREB regulated transcription coactivator 1	23373.0	19:18683678-18782333	1	Yes	19p13.11	yes		salivary gland mucoepidermoid			E	Dom	oncogene, fusion	T	MAML2			CCDS42525.1,ENSG00000105662.15,FLJ14027,KIAA0616,MECT1,NM_001098482.1,NP_001091952,Q6UUV9,TORC1
CSF1R	colony stimulating factor 1 receptor	1436.0	5:150053291-150113372	2		5q32	yes		MDS, CML, AML, hemangioblastoma, CCRCC			L, M, E		oncogene	Mis, N		yes	diffuse leukoencephalopathy with spheroids	C-FMS,CCDS4302.1,CD115,CSFR,ENSG00000182578.13,FMS,NM_005211.3,NP_001275634,NP_005202,NP_001336665.1,P07333
CSF3R	colony stimulating factor 3 receptor (granulocyte)	1441.0	1:36466043-36483278	1	Yes	1p34.3	yes		aCML, CNL,  leukaemia lymphoma and MDS associated with severe congenital neutropenia, CMML, de novo AML, MDS			L	Dom	oncogene	Mis, N		yes	Kostmann syndrome, severe congenital neutropenia	CCDS414.1,CD114,ENSG00000119535.17,GCSFR,NM_156039.3,NP_724781,Q99062
CTNNA2	catenin alpha 2	1496.0	2:79651552-80648689	2		2p12	yes		gastric cancer			E		oncogene	Mis, S				CAP-R,CCDS62944.1,CT114,ENSG00000066032.18,NM_001282597.2,NP_001269526,P26232
CTNNB1	catenin (cadherin-associated protein), beta 1	1499.0	3:41220551-41239888	1	Yes	3p22.1	yes		colorectal, ovarian,  hepatoblastoma, pleomorphic salivary gland adenoma, other tumour types			E, M, O	Dom	oncogene, fusion	Mis, O, T	PLAG1			CCDS2694.1,CTNNB,ENSG00000168036.17,armadillo,beta-catenin
CTNND2	catenin delta 2	1501.0	5:10971840-11904043	2		5p15.2	yes		prostae adenocarcinoma, GIST			E		oncogene	Mis				CCDS3881.1,ENSG00000169862.18,GT24,NM_001332.3,NPRAP,NP_001323,Q9UQB3
CUX1	cut-like homeobox 1	1523.0	7:101816011-102258233	1	Yes	7q22.1	yes		endometrial, melanoma, colorectal, AML, MDS, other tumour types			E,L,M,O	Dom	oncogene, TSG	N,F,S,Mis,O,T	CLDN7			CASP,CCDS56498.1,CDP,CDP/Cut,CDP/Cux,CDP1,CUT,CUTL1,CUX,Clox,Cux/CDP,ENSG00000257923.10,GOLIM6,NM_001202543.1,NP_001189472,P39880
CXCR4	C-X-C motif chemokine receptor 4	7852.0	2:136114349-136116243	1	Yes	2q22.1	yes	yes	WM			L	Dom	oncogene	Mis, N, F				CCDS33295.1,CD184,D2S201E,ENSG00000121966.6,HM89,HSY3RR,LESTR,NM_001008540.1,NPY3R,NPYR,NPYY3R,NP_001008540,P61073,fusin
CYSLTR2	cysteinyl leukotriene receptor 2	57105.0	13:48706555-48711226	2		13q14.2	yes		uveal melanoma			E		oncogene	Mis				CCDS9412.1,CYSLT2R,CysLT(2),ENSG00000152207.7,NM_001308471.1,NP_001295400,Q9NS75
DAXX	death-domain associated protein	1616.0	6:33318558-33323014	1	Yes	6p21.32	yes		pancreatic neuroendocrine tumour, paediatric glioblastoma			E	Rec	oncogene, TSG	Mis, F, N				CCDS4776.1,DAP6,ENSG00000204209.12,NM_001350.4,NP_001341,NP_001135441,NP_001135442.1,Q9UER7
DDB2	damage-specific DNA binding protein 2	1643.0	11:47214942-47239240	1	Yes	11p11.2		yes		skin basal cell, skin squamous cell, melanoma	xeroderma pigmentosum (E)	E	Rec	oncogene, TSG	Mis, N				CCDS7927.1,DDBB,ENSG00000134574.11,FLJ34321,NM_000107.2,NP_000098,Q92466,UV-DDB2,XPE
DDIT3	DNA-damage-inducible transcript 3	1649.0	12:57516589-57520517	1	Yes	12q13.3	yes		liposarcoma			M	Dom	oncogene, fusion	T	FUS, EWSR1			CCDS55838.1,CHOP,CHOP10,ENSG00000175197.12,GADD153,NM_001195056.1,NP_001181985,NP_001181983,NP_001181982,NP_001181984,P35638
DDR2	discoidin domain receptor 2	4921.0	1:162632465-162787400	1	Yes	1q23.3	yes		squamous cell carcinoma, NSCLC			E	Dom	oncogene	Mis, N		yes	Spondylometaepiphyseal dysplasia, short limb-hand type	CCDS1241.1,ENSG00000162733.16,NM_001014796.1,NP_001014796,NP_001341912.1,NP_001341911.1,NTRKR3,Q16832,TKT,TYRO10
DDX5	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5	1655.0	17:64499616-64506521	1	Yes	17q23.3	yes		prostate			E	Dom	oncogene, fusion	T	ETV4			CCDS11659.1,ENSG00000108654.14,G17P1,HLR1,NM_004396.4,NP_001307525,NP_004387,NP_001307524,P17844,p68
DDX6	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6	1656.0	11:118747766-118790948	1	Yes	11q23.3	yes		B-NHL			L	Dom	oncogene, fusion	T	IGH			CCDS44751.1,ENSG00000110367.11,HLR2,NM_001257191.2,NP_001244120,P26196,RCK
DEK	DEK oncogene (DNA binding)	7913.0	6:18223868-18264823	1		6p22.3	yes		AML			L	Dom	oncogene, fusion	T	NUP214			CCDS34344.1,D6S231E,ENSG00000124795.14,NM_003472.3,NP_003463,P35659
DGCR8	DGCR8, microprocessor complex subunit	54487.0	22:20080232-20111871	2		22q11.21	yes		Wilms tumour			O		oncogene	Mis				C22orf12,CCDS13773.1,DGCRK6,ENSG00000128191.15,Gy1,NM_022720.6,NP_073557,Q8WYQ5,pasha
EGFR	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)	1956.0	7:55019101-55211628	1	Yes	7p11.2	yes	yes	glioma, NSCLC	NSCLC	familial lung cancer	E, O	Dom	oncogene	A, O, Mis				CCDS5514.1,ENSG00000146648.17,ERBB,ERBB1,NM_005228.3,NP_005219,P00533
ELF4	E74-like factor 4 (ets domain transcription factor)	2000.0	X:130064928-130110495	1	Yes	Xq26.1	yes		AML			L	Dom	oncogene, TSG, fusion	T	ERG			CCDS14617.1,ELFR,ENSG00000102034.16,MEF,NM_001421.3,NP_001412,Q99607
ELK4	ELK4, ETS-domain protein (SRF accessory protein 1)	2005.0	1:205607943-205631962	1	Yes	1q32.1	yes		prostate			E	Dom	oncogene, fusion	T	SLC45A3			CCDS1456.1,ENSG00000158711.13,NM_001973.3,NP_001964,P28324,SAP1
EPAS1	endothelial PAS domain protein 1	2034.0	2:46297402-46386703	1	Yes	2p21	yes		paraganglioma, pheochromocytoma, central nervous system hemangioblastomas			E, M	Dom	oncogene, TSG	Mis		yes	type 3 familial erythrocytosis	CCDS1825.1,ENSG00000116016.13,HIF2A,HLF,MOP2,NM_001430.4,NP_001421,PASD2,Q99814,bHLHe73
ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)	2064.0	17:39700080-39728662	1	Yes	17q12	yes		breast, ovarian, other tumour types, NSCLC, gastric			E	Dom	oncogene, fusion	A, Mis, O				CCDS32642.1,CD340,ENSG00000141736.13,HER-2,HER2,NEU,NGL,NM_004448.3,NP_004439,P04626
ERBB3	erb-b2 receptor tyrosine kinase 3	2065.0	12:56079861-56103505	1	Yes	12q13.2	yes		colon, gastric, head and neck, bladder, skin			E	Dom	oncogene	Mis, N				CCDS31833.1,ENSG00000065361.15,HER3,LCCS2,NM_001982.3,NP_001973,P21860
ERBB4	erb-b2 receptor tyrosine kinase 4	2066.0	2:211375717-212538841	1	Yes	2q34	yes	yes	melanoma, gastric, NSCLC			E	Dom	oncogene, TSG	Mis, N		yes	Amyotrophic lateral sclerosis 19	ALS19,CCDS2394.1,ENSG00000178568.14,HER4,NM_005235.2,NP_005226,Q15303
ERG	v-ets erythroblastosis virus E26 oncogene like (avian)	2078.0	21:38380027-38661694	1	Yes	21q22.2	yes		Ewing sarcoma, prostate, AML			M, E, L	Dom	oncogene, fusion	T, A	EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1			CCDS46648.1,ENSG00000157554.18,NM_001243432.2,NP_001129626,NP_001230361.1,P11308,erg-3,p55
ESR1	estrogen receptor 1	2099.0	6:151690496-152103274	1	Yes	6q25.2	yes		breast			E	Dom	oncogene, TSG, fusion	Mis				CCDS5234.1,ENSG00000091831.23,ER-alpha,ESR,Era,NM_001122742.1,NP_001116214,NR3A1,P03372
ETV1	ets variant gene 1	2115.0	7:13891228-13989946	1		7p21.2	yes		Ewing sarcoma, prostate			M, E	Dom	oncogene, fusion	T	EWSR1, TMPRSS2, SLC45A3, HMGN2P46, HNRNPA2B1. ACSL3			CCDS55088.1,ENSG00000006468.13,ER81,NM_004956.4,NP_004947,P50549
ETV4	ets variant gene 4 (E1A enhancer binding protein, E1AF)	2118.0	17:43527844-43546432	1		17q21.31	yes		Ewing sarcoma, prostate carcinoma			M, E	Dom	oncogene, fusion	T	EWSR1, TMPRSS2, DDX5, KLK2, CANT1			CCDS11465.1,E1A-F,E1AF,ENSG00000175832.12,NM_001079675.2,NP_001073143,P43268,PEA3
ETV5	ets variant gene 5	2119.0	3:186046308-186109112	1		3q27.2	yes		prostate			E	Dom	oncogene, fusion	T	TMPRSS2, SCL45A3			CCDS33906.1,ENSG00000244405.7,ERM,NM_004454.2,NP_004445,P41161
EWSR1	Ewing sarcoma breakpoint region 1 (EWS)	2130.0	22:29268316-29300343	1	Yes	22q12.2	yes		Ewing sarcoma, desmoplastic small round cell tumour , ALL, clear cell sarcoma, sarcoma, myoepithelioma, mesothelioma			L, M, E	Dom	oncogene, fusion	T	FLI1, ERG, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1,  PBX1, NFATC1, NFATC2, DDIT3, PATZ1, SMARCA5, SP3, ZNF444, YY1			CCDS13852.2,ENSG00000182944.17,EWS,NM_013986.3,NP_053733,Q01844
EZH2	enhancer of zeste homolog 2	2146.0	7:148807385-148884278	1	Yes	7q36.1	yes		DLBCL			L	Dom	oncogene, TSG	Mis				CCDS5891.1,ENSG00000106462.10,ENX-1,EZH1,KMT6,KMT6A,NM_004456.4,NP_004447,Q15910
FCGR2B	Fc fragment of IgG, low affinity IIb, receptor for (CD32)	2213.0	1:161663161-161678654	1	Yes	1q23.3	yes		ALL			L	Dom	oncogene, fusion	T	?			CCDS30924.1,CD32,CD32B,ENSG00000072694.20,FCG2,FCGR2,NM_004001.4,NP_003992,NP_001002275.1,P31994
FCRL4	Fc receptor-like 4	83417.0	1:157573749-157598080	1		1q23.1	yes		B-NHL			L	Dom	oncogene, fusion	T	IGH			CCDS1166.1,CD307d,ENSG00000163518.10,FCRH4,IGFP2,IRTA1,NM_031282.2,NP_112572,Q96PJ5
FES	FES proto-oncogene, tyrosine kinase	2242.0	15:90884412-90895776	1	Yes	15q26.1	yes		HNSCC, ovarian carcinoma			E		oncogene, TSG	Mis, F				CCDS10365.1,ENSG00000182511.11,FPS,NM_002005.3,NP_001996,P07332
FEV	FEV protein - (HSRNAFEV)	54738.0	2:218981087-218985657	1		2q35	yes		Ewing sarcoma			M	Dom	oncogene, fusion	T	EWSR1,  FUS			CCDS2428.1,ENSG00000163497.2,NM_017521.2,NP_059991,Pet-1,Q99581
FGFR1	fibroblast growth factor receptor 1	2260.0	8:38411138-38467845	1	Yes	8p11.23	yes		MPN, NHL, salivary adenoma			L	Dom	oncogene, fusion	T	BCR, FOP, ZMYM2, CNTRL, PLAG1	yes	Pfeiffer syndrome, Kallman syndrome	BFGFR,CCDS55223.1,CD331,CEK,ENSG00000077782.19,FLG,FLT2,H2,H3,H4,H5,KAL2,N-SAM,NM_001174067.1,NP_001167538,P11362
FGFR2	fibroblast growth factor receptor 2	2263.0	10:121479857-121598403	1	Yes	10q26.13	yes		gastric, NSCLC, endometrial			E	Dom	oncogene, fusion	Mis		yes	Crouzon, Pfeiffer, and Apert syndromes	BEK,CCDS7620.2,CD332,CEK3,CFD1,ECT1,ENSG00000066468.22,JWS,K-SAM,KGFR,NM_022970.3,NP_075259,P21802,TK14,TK25
FGFR3	fibroblast growth factor receptor 3	2261.0	4:1793312-1808872	1	Yes	4p16.3	yes		bladder, MM, T-cell lymphoma			L, E	Dom	oncogene, fusion	Mis, T	IGH, ETV6	yes	Hypochondroplasia, Thanatophoric dysplasia	ACH,CCDS54706.1,CD333,CEK2,ENSG00000068078.18,JTK4,NM_001163213.1,NP_001156685.1,P22607
FGFR4	fibroblast growth factor receptor 4	2264.0	5:177086886-177098144	1	Yes	5q35.2	yes		rhabdomyosarcoma			M	Dom	oncogene	Mis				CCDS4410.1,CD334,ENSG00000160867.14,JTK2,NM_213647.2,NP_998812,NP_002002,NP_001341913.1,P22455
FLI1	Friend leukemia virus integration 1	2313.0	11:128693770-128813267	1		11q24.3	yes		Ewing sarcoma			M	Dom	oncogene, fusion	T	EWSR1			CCDS44768.1,ENSG00000151702.16,EWSR2,NM_002017.4,NP_002008,Q01543,SIC-1
FLT3	fms-related tyrosine kinase 3	2322.0	13:28003274-28100592	1	Yes	13q12.2	yes		AML, ALL			L	Dom	oncogene	Mis, O				CCDS31953.1,CD135,ENSG00000122025.14,FLK2,NM_004119.2,NP_004110,P36888,STK1
FLT4	fms-related tyrosine kinase 4	2324.0	5:180601506-180649624	1	Yes	5q35.3	yes		soft tissue sarcoma			M	Dom	oncogene	A				CCDS4457.1,ENSG00000037280.15,NM_182925.4,NP_891555,P35916,PCL,VEGFR3
FOXA1	forkhead box A1	3169.0	14:37589984-37595034	1	Yes	14q21.1	yes		breast, prostate			E	Dom	oncogene	Mis, F				CCDS9665.1,ENSG00000129514.5,HNF3A,NM_004496.3,NP_004487,P55317
FOXL2	forkhead box L2	668.0	3:138944224-138947140	1	Yes	3q22.3	yes		granulosa-cell tumour of the ovary			O	Dom	oncogene, TSG	Mis		yes	Blepharophimosis, ptosis and epicanthus inversus Types I, II; Premature ovarian failure type III	BPES,BPES1,CCDS3105.1,ENSG00000183770.5,NM_023067.3,NP_075555,P58012
FOXO1	forkhead box O1	2308.0	13:40555667-40666597	1		13q14.11	yes		alveolar rhabdomyosarcoma			M	Dom	oncogene, TSG, fusion	T	PAX3, PAX7			CCDS9371.1,ENSG00000150907.7,FKH1,FKHR,FOXO1A,NM_002015.3,NP_002006,Q12778
FOXO3	forkhead box O3	2309.0	6:108560866-108684768	1		6q21	yes		AL			L	Dom	oncogene, TSG, fusion	T	KMT2A			AF6q21,CCDS5068.1,ENSG00000118689.14,FKHRL1,FOXO2,FOXO3A,NM_001455.3,NP_001446,O43524
FOXO4	forkhead box O4	4303.0	X:71096197-71103535	1		Xq13.1	yes		AL, soft tissue sarcoma			L, M	Dom	oncogene, TSG, fusion	T	KMT2A, CIC			AFX1,CCDS43969.1,ENSG00000184481.16,MLLT7,NM_005938.3,NP_005929,P98177
FOXP1	forkhead box P1	27086.0	3:70954715-71583989	1		3p13	yes		ALL			L	Dom	oncogene, fusion	T	PAX5			12CC4,CCDS74964.1,ENSG00000114861.19,HSPC215,NM_001244810.1,NP_001231739,Q9H334,QRF1,hFKH1B
FOXR1	forkhead box R1	283150.0	11:118971707-118981291	2		11q23.3	yes		neuroblastoma			O		oncogene, fusion	T				CCDS31688.1,DLNB13,ENSG00000176302.12,FOXN5,NM_181721.2,NP_859072,Q6PIV2
FSTL3	follistatin-like 3 (secreted glycoprotein)	10272.0	19:676365-683399	1		19p13.3	yes		B-CLL			L	Dom	oncogene, fusion	T	CCND1			CCDS12040.1,ENSG00000070404.9,FLRG,FSRP,NM_005860.2,NP_005851,O95633
FUBP1	far upstream element (FUSE) binding protein 1	8880.0	1:77948405-77979086	1	Yes	1p31.1	yes		oligodendroglioma			O	Rec	oncogene	F, N				CCDS683.1,ENSG00000162613.16,FBP,FUBP,NM_003902.4,NP_003893,NP_001290362.1,Q96AE4
GATA1	GATA binding protein 1 (globin transcription factor 1)	2623.0	X:48786554-48794308	1	Yes	Xp11.23	yes		megakaryoblastic leukaemia of Downs syndrome			L	Dom	oncogene, TSG	Mis, F				CCDS14305.1,ENSG00000102145.13,ERYF1,GATA-1,GF1,NF-E1,NFE1,NM_002049.3,NP_002040,P15976
GATA2	GATA binding protein 2	2624.0	3:128479427-128493185	1	Yes	3q21.3	yes		AML (CML blast transformation)			L	Dom	oncogene	Mis				CCDS3049.1,ENSG00000179348.11,NFE1B,NM_032638.4,NP_116027,P23769
GATA3	GATA binding protein 3	2625.0	10:8054653-8075203	1	Yes	10p14	yes		breast			E	Rec	oncogene, TSG	F, N, S		yes	HDR syndrome (hypoparathyroidism, sensorineural deafness, and renal disease)	CCDS31143.1,ENSG00000107485.16,HDR,NM_001002295.1,NP_001002295,P23771
GLI1	GLI family zinc finger 1	2735.0	12:57460138-57472262	2		12q13.3	yes		CRC, oesophagus cancer			E		oncogene, fusion	T, F		yes	IBD	CCDS8940.1,ENSG00000111087.9,GLI,NM_005269.2,NP_005260,P08151
GNA11	guanine nucleotide binding protein (G protein), alpha 11 (Gq class)	2767.0	19:3094410-3124004	1	Yes	19p13.3	yes		uveal melanoma, primary central nervous system melanocytic neoplasms			E, O	Dom	oncogene	Mis				CCDS12103.1,ENSG00000088256.8,FBH,FBH2,FHH2,HHC2,NM_002067.4,NP_002058,P29992
GNAQ	guanine nucleotide binding protein (G protein), q polypeptide	2776.0	9:77716087-78031458	1	Yes	9q21.2	yes		uveal melanoma, primary central nervous system melanocytic neoplasms			E, O	Dom	oncogene	Mis				CCDS6658.1,ENSG00000156052.10,G-ALPHA-q,GAQ,NM_002072.4,NP_002063,P50148
GNAS	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	2778.0	20:58852714-58911192	1	Yes	20q13.32	yes		pituitary adenoma, pancreatic intraductal papillary mucinous neoplasm, fibrous dysplasia			E, M	Dom	oncogene	Mis		yes	McCune-Albright syndrome; pseudohypoparathyroidism, type IA	CCDS46622.1,ENSG00000087460.24,GNAS1,GNASXL,GPSA,NESP,NESP55,NM_080425.3,NP_536350,Q5JWF2,SCG6,SgVI
GPC3	glypican 3	2719.0	X:133535754-133985646	1	Yes	Xq26.2		yes		Wilms tumour	Simpson-Golabi-Behmel syndrome	O	Rec/X	oncogene, TSG	D, Mis, N, F, S				CCDS55496.1,DGSX,ENSG00000147257.13,NM_001164617.1,NP_001158089,OCI-5,P51654,SDYS,SGB,SGBS,SGBS1
GRM3	glutamate metabotropic receptor 3	2913.0	7:86643914-86864884	2		7q21.12	yes		melanoma, oral SCC			E		oncogene	Mis, A				CCDS5600.1,ENSG00000198822.10,GPRC1C,MGLUR3,NM_000840.2,NP_000831,Q14832,mGlu3
H3F3A	H3 histone, family 3A	3020.0	1:226063977-226072001	1	Yes	1q42.12	yes		glioma			O	Dom	oncogene	Mis				CCDS1550.1,ENSG00000163041.9,H3.3A,H3F3,P84243
H3F3B	H3 histone, family 3B (H3.3B)	3021.0	17:75776434-75779779	1	Yes	17q25.1	yes		chondroblastoma			M	Dom	oncogene	Mis				CCDS11729.1,ENSG00000132475.10,H3.3B,NM_005324.4,NP_005315,P84243
HEY1	hairy/enhancer-of-split related with YRPW motif 1	23462.0	8:79764013-79767857	1	Yes	8q21.13	yes		mesenchymal chondrosarcoma			M	Dom	oncogene, fusion	T	NCOA2			CCDS43749.1,CHF-2,CHF2,ENSG00000164683.16,HERP2,HESR-1,HESR1,HRT-1,NM_001040708.1,NP_001035798,Q9Y5J3,bHLHb31
HGF	Hepatocyte growth factor	3082.0	7:81699008-81770198	1		7q21.11	yes	yes	breast cancer, lung cancer, multiple myeloma	bladder cancer		E, M		oncogene, fusion	A, F, Mis, N, T	CACNA2D1			CCDS5597.1,DFNB39,ENSG00000019991.16,F-TCF,HGFB,HPTA,NM_000601.5,NP_000592,P14210,SF
HIF1A	hypoxia inducible factor 1 alpha subunit	3091.0	14:61697622-61748259	1	Yes	14q23.2	yes		endometrioid carcinoma, glioblastoma, colorectal, renal, lung, pancreatic			E, O	Dom	oncogene	Mis, F, N				CCDS58324.1,ENSG00000100644.16,HIF-1alpha,HIF1,MOP1,NM_001243084.1,NP_001230013,PASD8,Q16665,bHLHe78
HIP1	huntingtin interacting protein 1	3092.0	7:75533300-75738947	1	Yes	7q11.23	yes		CMML, NSCLC			L, E	Dom	oncogene, fusion	T	PDGFRB, ALK			CCDS34669.1,ENSG00000127946.16,ILWEQ,NM_005338.6,NP_005329,O00291
HIST1H3B	histone cluster 1, H3b	8358.0	6:26031650-26032060	1	Yes	6p22.2	yes		glioma			O	Dom	oncogene	Mis				CCDS4573.1,ENSG00000274267.1,H3/l,H3FL,NM_003537.3,NP_003528,P68431
HLF	hepatic leukemia factor	3131.0	17:55265012-55325065	1		17q22	yes		ALL			L	Dom	oncogene, fusion	T	TCF3			CCDS11585.1,ENSG00000108924.13,MGC33822,NM_002126.4,NP_002117,Q16534
HMGA1	high mobility group AT-hook 1	3159.0	6:34236873-34246230	1		6p21.31	yes		microfollicular thyroid adenoma, various benign mesenchymal tumours			E, M	Dom	oncogene, fusion	T	?			CCDS4789.1,ENSG00000137309.19,HMGIY,NM_145901.2,NP_665908,NP_001306010,NP_001306007,P17096
HMGA2	high mobility group AT-hook 2 (HMGIC)	8091.0	12:65824460-65915447	1		12q14.3	yes		lipoma, leiomyoma, pleomorphic salivary gland adenoma			M	Dom	oncogene, fusion	T	LHFP, RAD51B, LPP, COX6C, ACKR3, NFIB, ALDH2, CCNB1IP1, EBF1, WIF1, FHIT			BABL,CCDS73491.1,ENSG00000149948.13,HMGIC,LIPO,NM_001300919.1,NP_001287848
HNRNPA2B1	heterogeneous nuclear ribonucleoprotein A2/B1	3181.0	7:26189927-26200746	1	Yes	7p15.2	yes		prostate			E	Dom	oncogene, fusion	T	ETV1			CCDS43557.1,ENSG00000122566.20,HNRPA2B1,NM_031243.2,NP_112533,P22626
HOXA11	homeo box A11	3207.0	7:27181515-27185216	1	Yes	7p15.2	yes		CML			L	Dom	oncogene, TSG, fusion	T	NUP98			CCDS5411.1,ENSG00000005073.5,HOX1,HOX1I,NM_005523.5,NP_005514,P31270
HOXA13	homeo box A13	3209.0	7:27194364-27200106	1		7p15.2	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS5412.1,ENSG00000106031.7,HOX1,HOX1J,NM_000522.4,NP_000513,P31271
HOXA9	homeo box A9	3205.0	7:27162435-27165530	1		7p15.2	yes		AML*			L	Dom	oncogene, TSG, fusion	T	NUP98, MSI2			CCDS5409.1,ENSG00000078399.17,HOX1,HOX1G,NM_152739.3,NP_689952,P31269
HOXC11	homeo box C11	3227.0	12:53973126-53977643	1		12q13.13	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS8867.1,ENSG00000123388.4,HOX3H,NM_014212.3,NP_055027,O43248
HOXC13	homeo box C13	3229.0	12:53938765-53946544	1		12q13.13	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS8865.1,ENSG00000123364.4,HOX3,HOX3G,NM_017410.2,NP_059106,P31276
HOXD11	homeo box D11	3237.0	2:176107286-176109588	1		2q31.1	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS2265.1,ENSG00000128713.13,HOX4,HOX4F,NM_021192.2,NP_067015,P31277
HOXD13	homeo box D13	3239.0	2:176092891-176095938	1		2q31.1	yes		AML*			L	Dom	oncogene, fusion	T	NUP98			CCDS2264.2,ENSG00000128714.5,HOX4I,NM_000523.3,NP_000514,P35453,SPD
HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog	3265.0	11:532243-535550	1	Yes	11p15.5	yes	yes	infrequent sarcomas, rare other tumour types	rhabdomyosarcoma, ganglioneuroblastoma, bladder	Costello syndrome	E, L, M	Dom	oncogene	Mis				CCDS7698.1,ENSG00000174775.16,HRAS1,NM_005343.3,NP_001123914,NP_005334,NP_001304983.1,P01112
IDH1	isocitrate dehydrogenase 1 (NADP+), soluble	3417.0	2:208236265-208254322	1	Yes	2q34	yes		glioblastoma			O	Dom	oncogene	Mis				CCDS2381.1,ENSG00000138413.13,NM_001282387.1,NP_001269316,O75874
IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial	3418.0	15:90083045-90102504	1	Yes	15q26.1	yes		glioblastoma			O	Dom	oncogene	Mis				CCDS10359.1,ENSG00000182054.9,NM_002168.3,NP_002159,P48735
IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	3551.0	8:42271302-42331608	1	Yes	8p11.21	yes		SMZL			L	Dom	oncogene	Mis		yes	Immunodeficiency 15	CCDS6128.1,ENSG00000104365.13,IKK-beta,IKK2,IKKB,NFKBIKB,NM_001556.2,NP_001547,O14920
IKZF3	IKAROS Family Zinc Finger 3	22806.0	17:39757715-39864188	1		17q21.1	yes		B-ALL, CLL, breast cancer, colorectal cancer			L, E		oncogene, TSG, fusion	D, Mis, F, N, T	NAGLU, VAPB			Aiolos,CCDS11346.1,ENSG00000161405.16,NM_012481.4,NP_036613,Q9UKT9,ZNFN1A3
IL6ST	interleukin 6 signal transducer (gp130, oncostatin M receptor)	3572.0	5:55935095-55994993	1	Yes	5q11.2	yes		hepatocellular carcinoma			E	Dom	oncogene	O				CCDS3971.1,CD130,ENSG00000134352.19,GP130,NM_002184.3,NP_002175,P40189
IL7R	interleukin 7 receptor	3575.0	5:35856849-35879603	1	Yes	5p13.2	yes		ALL, ETP ALL			L	Dom	oncogene	Mis, O		yes	Severe combined immune deficiency	CCDS3911.1,CD127,ENSG00000168685.14,IL7RA,NM_002185.3,NP_002176,P16871
IRF4	interferon regulatory factor 4	3662.0	6:391739-411447	1		6p25.3	yes		MM			L	Dom	oncogene, TSG, fusion	T	IGH			CCDS4469.1,ENSG00000137265.14,LSIRF,MUM1,NM_002460.3,NP_002451,NP_001182215.1,Q15306
IRS4	insulin receptor substrate 4	8471.0	X:108732482-108736409	1	Yes	Xq22.3	yes		glioma, rhabdomyosarcoma, melanoma, breast cancer, T-ALL			E, O, M, L		oncogene, TSG	Mis, F, T	TRB			CCDS14544.1,ENSG00000133124.11,IRS-4,NM_003604.2,NP_003595,O14654,PY160
JAK1	Janus kinase 1	3716.0	1:64833229-64966504	1	Yes	1p31.3	yes		ALL			L	Dom	oncogene, TSG	Mis				CCDS41346.1,ENSG00000162434.11,JAK1A,JAK1B,JTK3,NM_002227.3,NP_002218,NP_001308782,NP_001307852,NP_001308784,NP_001308785,NP_001308781,NP_001308783,NP_001308786.1,P23458
JAK2	Janus kinase 2	3717.0	9:4985245-5128183	1	Yes	9p24.1	yes		ALL, AML, MPN,  CML			L	Dom	oncogene, fusion	T, Mis, O	ETV6, PCM1, BCR			CCDS6457.1,ENSG00000096968.13,JTK10,NM_004972.3,NP_004963,NP_001309125,NP_001309123,NP_001309124,NP_001309133.1,NP_001309127.1,NP_001309128.1,O60674
JAK3	Janus kinase 3	3718.0	19:17824786-17848032	1	Yes	19p13.11	yes		acute megakaryocytic leukaemia, ETP ALL			L	Dom	oncogene	Mis				CCDS12366.1,ENSG00000105639.18,JAK-3,JAK3_HUMAN,JAKL,L-JAK,LJAK,NM_000215.3,NP_000206,P52333
JUN	jun oncogene	3725.0	1:58780788-58784327	1		1p32.1	yes		sarcoma			M	Dom	oncogene	A				AP-1,CCDS610.1,ENSG00000177606.6,NM_002228.3,NP_002219,P05412,c-Jun
KAT6A	K(lysine) acetyltransferase 6A	7994.0	8:41929479-42051987	1		8p11.21	yes		AML			L	Dom	oncogene, fusion	T, A	CREBBP, NCOA2, EP300			CCDS6124.1,ENSG00000083168.9,MOZ,MYST3,Q92794,RUNXBP2,ZC2HC6A,ZNF220
KAT7	lysine acetyltransferase 7	11143.0	17:49788555-49835030	2		17q21.33	yes		CCRCC			E		oncogene	Mis				CCDS11554.1,ENSG00000136504.11,HBO1,HBOA,MYST2,NM_007067.4,NP_008998,O95251,ZC2HC7
KCNJ5	potassium inwardly-rectifying channel; subfamily J; member 5	3762.0	11:128891356-128921035	1		11q24.3	yes		adrenal adenoma			E	Dom	oncogene	Mis		yes	Familial hyperaldosteronism type III, Long QT syndrome	CCDS8479.1,CIR,ENSG00000120457.11,GIRK4,KATP1,Kir3.4,LQT13,NM_001354169.1,NP_000881,NP_001341098.1,P48544
KDM5A	lysine (K)-specific demethylase 5A, JARID1A	5927.0	12:280129-389454	1		12p13.33	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS41736.1,ENSG00000073614.12,JARID1A,NM_001042603.2,NP_001036068,P29375,RBBP2
KDM6A	lysine (K)-specific demethylase 6A, UTX	7403.0	X:44873511-45112602	1	Yes	Xp11.3	yes		renal cell carcinoma, bladder carcinoma, oesophageal SCC, MM, medulloblastoma, T-ALL, other tumour types			E, L	Rec	oncogene, TSG	D, N, F, S		yes	Kabuki syndrome	CCDS14265.1,ENSG00000147050.14,NM_021140.3,NP_066963,O15550,UTX
KDR	vascular endothelial growth factor receptor 2	3791.0	4:55078259-55125595	1	Yes	4q12	yes	yes	NSCLC, angiosarcoma	melanoma		E	Dom	oncogene	Mis				CCDS3497.1,CD309,ENSG00000128052.9,FLK1,NM_002253.2,NP_002244,VEGFR,VEGFR2
KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	3815.0	4:54657918-54740715	1	Yes	4q12	yes	yes	GIST, AML, TGCT, mastocytosis, mucosal melanoma	GIST, epithelioma	familial gastrointestinal stromal tumour	L, M, O, E	Dom	oncogene	Mis, O		yes	Piebald trait	C-Kit,CCDS3496.1,CD117,ENSG00000157404.15,NM_000222.2,NP_000213,P10721,PBT,SCFR
KLF4	Kruppel-like factor 4	9314.0	9:107484852-107489646	1	Yes	9q31.2	yes		meningioma			O	Dom	oncogene, TSG	Mis				CCDS6770.2,ENSG00000136826.14,EZF,GKLF,NM_004235.5,NP_004226,NP_001300981.1,O43474
KMT2A	lysine (K)-specific methyltransferase 2A	4297.0	11:118436490-118526832	1	Yes	11q23.3	yes		AML, ALL			L	Dom	oncogene, fusion	T, O	KMT2A, MLLT1, AFF1, MLLT3, MLLT4, FOXO4, MLLT10, MLLT6, ELL, EPS15, MLLT11, CREBBP, SH3GL1, FNBP1, SEPT5, SEPT9, GPHN, GMPS, ABI1, ARHGEF12, GAS7, FOXO3, AFF3, TET1, SEPT6, LPP, RUNX1T1, ARHGAP26, EP300, PICALM, CLP1, PRRC1, DAB2IP, MAPRE1, KIAA1524, SEPT2, SARNP, ZFYVE19, TOP3A, CASC5, EEFSEC, FRYL, SORBS2, ABI2, LASP1, CASP8AP2, AFF4, NRIP3, NCKIPSD, CBL, ACTN4, PDS5A, CT45A2, MYO1F, KIAA0284, BTBD18			ALL-1,CCDS55791.1,CXXC7,ENSG00000118058.20,HRX,HTRX1,MLL,MLL1A,NM_001197104.1,NP_001184033,Q03164,TRX1
KMT2D	lysine (K)-specific methyltransferase 2D	8085.0	12:49018975-49055324	1	Yes	12q13.12	yes		medulloblastoma, renal			O, E	Rec	oncogene, TSG	N, F, Mis				ALR,CAGL114,CCDS44873.1,ENSG00000167548.14,MLL2,MLL4,NM_003482.3,NP_003473,O14686,TNRC21
KNSTRN	kinetochore localized astrin/SPAG5 binding protein	90417.0	15:40382721-40394245	2		15q15.1	yes		SCC			E		oncogene	Mis				C15orf23,CCDS42021.1,ENSG00000128944.13,FLJ14502,NM_033286.3,NP_150628,Q9Y448,SKAP,TRAF4AF1,kinastrin
KRAS	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog	3845.0	12:25209431-25250803	1	Yes	12p12.1	yes		pancreatic, colorectal, lung, thyroid, AML, other tumour types			L, E, M, O	Dom	oncogene	Mis				CCDS8703.1,ENSG00000133703.11,KRAS1,KRAS2,NM_033360.3,NP_203524,P01116
LCK	lymphocyte-specific protein tyrosine kinase	3932.0	1:32251239-32286165	1	Yes	1p35.2	yes		T-ALL			L	Dom	oncogene, fusion	T	TRB			CCDS359.1,ENSG00000182866.16,NM_005356.4,NP_005347,P06239
LEF1	lymphoid enhancer binding factor 1	51176.0	4:108047545-108168422	1	Yes	4q25	yes		B-ALL, T-ALL, eyelid sebaceous carcinoma, AML, lymphomas			L, E		oncogene, TSG	Mis, N				CCDS3679.1,ENSG00000138795.9,NM_016269.4,NP_057353,Q9UJU2,TCF10,TCF1ALPHA,TCF7L3
LMO1	LIM domain only 1 (rhombotin 1) (RBTN1)	4004.0	11:8224304-8263858	1		11p15.4	yes	yes	T-ALL, neuroblastoma	neuroblastoma		L	Dom	oncogene, fusion	T, A	TRD			CCDS44534.1,ENSG00000166407.13,NM_002315.2,NP_002306,P25800,RBTN1,RHOM1,TTG1
LMO2	LIM domain only 2 (rhombotin-like 1) (RBTN2)	4005.0	11:33858576-33892289	1		11p13	yes		T-ALL			L	Dom	oncogene, fusion	T	TRD			CCDS7888.2,ENSG00000135363.11,NM_005574.3,NP_005565,P25791,RBTN2,RBTNL1,RHOM2,TTG2
LPP	LIM domain containing preferred translocation partner in lipoma	4026.0	3:188212933-188890671	1		3q28	yes		lipoma, leukaemia			L, M	Dom	oncogene, fusion	T	HMGA2, KMT2A, C12orf9			CCDS3291.1,ENSG00000145012.13,NM_005578.4,NP_005569,Q93052
LYL1	lymphoblastic leukemia derived sequence 1	4066.0	19:13099033-13102867	1		19p13.13	yes		T-ALL			L	Dom	oncogene, fusion	T	TRB			CCDS12292.1,ENSG00000104903.4,NM_005583.4,NP_005574,P12980,bHLHa18
LYN	LYN Proto-Oncogene	4067.0	8:55879813-56010572	2		8q12.1	yes		DLBCL, B-ALL, MPN			L		oncogene, fusion	Mis, T	ETV6, GATAD2A, NCOR1			CCDS6162.1,ENSG00000254087.7,JTK8,NM_002350.3,NP_002341,P07948
MACC1	MET transcriptional regulator MACC1	346389.0	7:20134655-20217390	2		7p21.1	yes		liver, CRC			E		oncogene	Mis				7A5,CCDS5369.1,ENSG00000183742.12,NM_182762.3,NP_877439,Q6ZN28,SH3BP4L
MAF	v-maf musculoaponeurotic fibrosarcoma oncogene homolog	4094.0	16:79593838-79600714	1		16q23.2	yes		MM			L	Dom	oncogene, fusion	T	IGH			CCDS10928.1,ENSG00000178573.6,NM_005360.4,NP_005351,O75444,c-MAF
MAFB	v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)	9935.0	20:40685848-40689240	1		20q12	yes		MM			L	Dom	oncogene, fusion	T	IGH			CCDS13311.1,ENSG00000204103.3,KRML,NM_005461.4,NP_005452,Q9Y5Q3
MALAT1	metastasis associated lung adenocarcinoma transcript 1 ( lnc-RNA; non-protein coding)		11:65497762-65506469	2		11q13.1	yes		renal cell carcinoma (childhood epithelioid), lung			E	Dom	oncogene, TSG, fusion	T	TFEB			
MALT1	mucosa associated lymphoid tissue lymphoma translocation gene 1	10892.0	18:58671386-58754477	1		18q21.32	yes		MALT			L	Dom	oncogene, fusion	T	BIRC3			CCDS11967.1,ENSG00000172175.12,MLT,NM_006785.3,NP_006776,PCASP1,Q9UDY8
MAML2	mastermind-like 2 (Drosophila)	84441.0	11:95976598-96343180	1		11q21	yes		salivary gland mucoepidermoid			E	Dom	oncogene, fusion	T	CRTC3, CRTC1			CCDS44714.1,ENSG00000184384.13,KIAA1819,MAM3,NM_032427.3,NP_115803,Q8IZL2
MAP2K1	mitogen-activated protein kinase kinase 1	5604.0	15:66386817-66492312	1	Yes	15q22.31	yes		NSCLC, melanoma, colorectal			E	Dom	oncogene	Mis		yes	Cardiofaciocutaneous syndrome	CCDS10216.1,ENSG00000169032.9,MAPKK1,MEK1,NM_002755.3,NP_002746,PRKMK1,Q02750
MAP2K2	mitogen-activated protein kinase kinase 2	5605.0	19:4090321-4124129	1	Yes	19p13.3	yes		NSCLC, melanoma			E	Dom	oncogene	Mis		yes	Cardiofaciocutaneous syndrome	CCDS12120.1,ENSG00000126934.13,MEK2,NM_030662.3,NP_109587,P36507,PRKMK2
MAP2K4	mitogen-activated protein kinase kinase 4	6416.0	17:12020834-12143830	1	Yes	17p12	yes		pancreatic, breast, colorectal			E	Rec	oncogene, TSG	D, Mis, N				CCDS62095.1,ENSG00000065559.14,JNKK1,MEK4,MKK4,NM_001281435.1,NP_001268364,P45985,PRKMK4,SERK1
MAP3K1	mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase	4214.0	5:56815574-56896152	1	Yes	5q11.2	yes		luminal A breast			E	Rec	oncogene, TSG	N, F, Mis, O, S		yes	46,XY sex reversal 6	CCDS43318.1,ENSG00000095015.5,MAPKKK1,MEKK,MEKK1,NM_005921.1,NP_005912,Q13233
MAP3K13	mitogen-activated protein kinase kinase kinase 13	9175.0	3:185363120-185489097	1	Yes	3q27.2	yes		breast			E	Rec	oncogene, TSG	F				CCDS3270.1,ENSG00000073803.13,LZK,MEKK13,NM_004721.4,NP_004712,O43283
MAPK1	mitogen-activated protein kinase 1	5594.0	22:21754500-21867629	1	Yes	22q11.22	yes		CLL, ovarian mixed germ cell tumour, cervical carcinoma			E, L	Dom	oncogene	Mis				CCDS13795.1,ENSG00000100030.14,ERK,ERK2,MAPK2,NM_002745.4,NP_002736,P28482,PRKM1,PRKM2,p41mapk
MDM2	Mdm2 p53 binding protein homolog	4193.0	12:68808176-68850686	1		12q15	yes		sarcoma, glioma, colorectal, other tumour types			M, O, E, L	Dom	oncogene	A				CCDS8986.2,ENSG00000135679.23,HDM2,MGC5370,NM_002392.5,NP_002383,Q00987
MDM4	Mdm4 p53 binding protein homolog	4194.0	1:204516383-204558120	1		1q32.1	yes		glioblastoma, bladder, retinoblastoma			M	Dom	oncogene	A				CCDS1447.1,ENSG00000198625.12,HDMX,MDMX,NM_002393.4,NP_002384,O15151
MECOM	MDS1 and EVI1 complex locus	2122.0	3:169083499-169146305	1		3q26.2	yes		AML, CML, MDS			L	Dom	oncogene, fusion	T	RUNX1, ETV6, PRDM16, RPN1			CCDS54670.1,ENSG00000085276.17,EVI1,KMT8E,MDS1,MDS1-EVI1,NM_001105077.3,NP_001098547,PRDM3,Q03112
MET	met proto-oncogene (hepatocyte growth factor receptor)	4233.0	7:116672405-116796342	1	Yes	7q31.2	yes		papillary renal, head-neck squamous cell	papillary renal	familial papillary renal cancer	E	Dom	oncogene	Mis				CCDS47689.1,DFNB97,ENSG00000105976.14,HGFR,NM_001127500.2,NP_001120972,P08581,RCCP2
MITF	melanogenesis-associated transcription factor	4286.0	3:69739435-69968336	1		3p13	yes		melanoma			E	Dom	oncogene	A		yes	Waardenburg syndrome type 2, Tietz syndrome	CCDS43106.1,ENSG00000187098.15,MI,NM_198159.2,NP_937802,NP_001341534.1,NP_001341535.1,NP_001341533.1,O75030,WS2,WS2A,bHLHe32
MLLT10	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10)	8028.0	10:21534343-21743630	1	Yes	10p12.31	yes		AL			L	Dom	oncogene, fusion	T	KMT2A, PICALM, CDK6			AF10,CCDS55708.1,ENSG00000078403.16,P55197
MN1	MN1 proto-oncogene, transcriptional regulator	4330.0	22:27748277-27801498	1		22q12.1	yes		AML, MDS			L	Dom	oncogene, fusion	T	ETV6			CCDS42998.1,ENSG00000169184.5,MGCR,MGCR1,MGCR1-PEN,NM_002430.2,NP_002421,Q10571
MPL	myeloproliferative leukaemia virus oncogene, thrombopoietin receptor	4352.0	1:43337849-43352772	1	Yes	1p34.2	yes	yes	MPN	MPN	familial essential thrombocythemia	L	Dom	oncogene	Mis		yes	Congenital amegakaryocytic thrombocytopenia	CCDS483.1,CD110,ENSG00000117400.17,NM_005373.2,NP_005364,P40238,TPOR
MRTFA	megakaryoblastic leukemia (translocation) 1	57591.0	22:40411390-40533635	1		22q13.2	yes		acute megakaryocytic leukaemia			L	Dom	oncogene, TSG, fusion	T	RBM15			BSAC,CCDS82720.1,ENSG00000196588.15,KIAA1438,MAL,MKL,MKL1,MRTF-A,NM_001318139.1,NP_001305068
MSI2	musashi homolog 2 (Drosophila)	124540.0	17:57256534-57684685	1		17q22	yes		CML			L	Dom	oncogene, fusion	T	HOXA9			CCDS11596.1,ENSG00000153944.10,NM_138962.3,NP_620412,Q96DH6
MTCP1	mature T-cell proliferation 1	4515.0	X:155064034-155071226	1		Xq28	yes		T cell prolymphocytic leukaemia			L	Dom	oncogene, fusion	T	TRA			CCDS44027.1,ENSG00000214827.9,NM_001018025.3,NP_001018025,P13MTCP1,P56278,p8MTCP1
MTOR	mechanistic target of rapamycin	2475.0	1:11106535-11262507	1	Yes	1p36.22	yes		endometrial carcinoma, head and neck, clear cell renal cell carcinoma, anaplastic thyroid cancer, urothelial cell carcinoma, central nervous system tumours, testicular germ cell tumours and other tumour types			E	Dom	oncogene	Mis, N		yes	Smith-Kingsmore syndrome, brain overgrowth phenotypes such as focal cortical dysplasia and megalencephaly,	CCDS127.1,ENSG00000198793.12,FLJ44809,FRAP,FRAP1,FRAP2,NM_004958.3,NP_004949,P42345,RAFT1,RAPT1
MUC16	mucin 16, cell surface associated	94025.0	19:8848844-8981342	2		19p13.2	yes		HNSCC, melanoma			E		oncogene	Mis				CA125,CCDS54212.1,ENSG00000181143.15,FLJ14303,NM_024690.2,NP_078966,Q8WXI7
MUC4	mucin 4, cell surface associated	4585.0	3:195746765-195812277	2		3q29	yes		HNSCC			E		oncogene	Mis, O				CCDS54700.1,ENSG00000145113.21,NM_018406.6,NP_060876
MYB	v-myb myeloblastosis viral oncogene homolog	4602.0	6:135181315-135219167	1		6q23.3	yes		adenoid cystic carcinoma			E	Dom	oncogene, fusion	T	NFIB			CCDS47481.1,ENSG00000118513.18,NM_001130173.1,NP_001123645,P10242,c-myb
MYC	v-myc myelocytomatosis viral oncogene homolog (avian)	4609.0	8:127736069-127741434	1	Yes	8q24.21	yes		Burkitt lymphoma, amplified in other cancers, B-CLL			L, E	Dom	oncogene, fusion	A, T	IGK, BCL5, BCL7A , BTG1, TRA, IGH			CCDS6359.2,ENSG00000136997.17,MYCC,NM_002467.4,NP_002458,NP_002458.2,bHLHe39,c-Myc
MYCL	v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog	4610.0	1:39895426-39902013	1		1p34.2	yes		small cell lung carcinoma			E	Dom	oncogene	A				CCDS53300.1,ENSG00000116990.10,LMYC,MYCL1,NM_001033082.2,NP_001028254,P12524,bHLHe38
MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	4613.0	2:15940564-15947007	1		2p24.3	yes		neuroblastoma, Wilms tumour			O	Dom	oncogene	A, Mis		yes	Feingold syndrome 1	CCDS1687.1,ENSG00000134323.11,MYCNOT,N-myc,NMYC,NM_005378.5,NP_001280157,NP_005369,NP_001280162.1,P04198,bHLHe37
MYD88	myeloid differentiation primary response gene (88)	4615.0	3:38138478-38143019	1	Yes	3p22.2	yes		ABC-DLBCL			L	Dom	oncogene	Mis				CCDS54565.1,ENSG00000172936.12,NM_001172567.1,NP_001166038
MYOD1	myogenic differentiation 1	4654.0	11:17719568-17722131	1	Yes	11p15.1	yes		embryonal rhabdomyosarcoma			M	Dom	oncogene	Mis				CCDS7826.1,ENSG00000129152.3,MYF3,MYOD,NM_002478.4,NP_002469,P15172,PUM,bHLHc1
NCOA2	nuclear receptor coactivator 2 (TIF2)	10499.0	8:70109762-70403805	1	Yes	8q13.3	yes		AML, chondrosarcoma, rhabdomyosarcoma			L, M	Dom	oncogene, fusion	T	KAT6A, HEY1, NCOA2			CCDS47872.1,ENSG00000140396.12,GRIP1,KAT13C,NCoA-2,NM_006540.3,NP_001308636,NP_006531,NP_001308632,NP_001308641.1,NP_001308642.1,NP_001308640.1,Q15596,TIF2,bHLHe75
NFATC2	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2	4773.0	20:51386957-51542719	1		20q13.2	yes		Ewing sarcoma			M	Dom	oncogene, fusion	T	EWSR1			CCDS13437.1,ENSG00000101096.19,NF-ATP,NFAT1,NFATp,NM_173091.3,NP_775114,NP_001245226.1,Q13469
NFE2L2	nuclear factor (erythroid-derived 2)-like 2 (NRF2)	4780.0	2:177230305-177265131	1	Yes	2q31.2	yes		NSCLC, HNSCC			E	Dom	oncogene, TSG	Mis				CCDS42782.1,ENSG00000116044.15,NM_006164.4,NP_006155,NP_001300831.1,NP_001300832.1,NRF2,Q16236
NFKB2	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)	4791.0	10:102394597-102402524	1		10q24.32	yes		B-NHL			L	Dom	oncogene, TSG, fusion	T	IGH			CCDS41564.1,ENSG00000077150.18,LYT-10,NF-kB2,NM_001322935.1,NP_001309863,NP_001070962,NP_001309864.1,Q00653,p105,p49/p100,p52
NKX2-1	NK2 homeobox 1	7080.0	14:36516392-36520228	1		14q13.3	yes		NSCLC			E	Dom	oncogene, TSG	A				BCH,CCDS41945.1,ENSG00000136352.17,NKX2A,NM_001079668.2,NP_001073136,P43699,TITF1,TTF-1,TTF1
NOTCH1	Notch homolog 1, translocation-associated (Drosophila) (TAN1)	4851.0	9:136494433-136545786	1	Yes	9q34.3	yes		T-ALL, breast, bladder, skin SCC, lung SCC, head and neck SCC			L, E	Dom/Rec	oncogene, TSG, fusion	T, Mis, O	TRB, SEC16A, GABBR2			CCDS43905.1,ENSG00000148400.10,NM_017617.4,NP_060087,P46531,TAN1
NOTCH2	Notch homolog 2	4853.0	1:119911553-120069626	1	Yes	1p12	yes		marginal zone lymphoma, DLBCL, bladder			L, E	Dom/Rec	oncogene, TSG	N, F, Mis		yes	Hajdu-Cheney syndrome, serpentine fibula-polycystic kidney syndrome	CCDS908.1,ENSG00000134250.19,NM_024408.3,NP_077719,NP_001186930.1,Q04721
NPM1	nucleophosmin (nucleolar phosphoprotein B23, numatrin)	4869.0	5:171387648-171411137	1	Yes	5q35.1	yes		NHL, APL, AML			L	Dom	oncogene, fusion	T, F	ALK, RARA, MLF1			B23,CCDS4376.1,ENSG00000181163.13,NM_002520.6,NPM,NP_002511,P06748
NR4A3	nuclear receptor subfamily 4, group A, member 3 (NOR1)	8013.0	9:99821855-99866891	1		9q31.1	yes		extraskeletal myxoid chondrosarcoma			M	Dom	oncogene, fusion	T	EWSR1, TAF15, TCF12, TFG			CCDS6742.1,CHN,CSMF,ENSG00000119508.17,MINOR,NM_173200.2,NOR1,NP_775292,Q92570
NRAS	neuroblastoma RAS viral (v-ras) oncogene homolog	4893.0	1:114704469-114716894	1	Yes	1p13.2	yes		melanoma, MM, AML, thyroid			L, E	Dom	oncogene	Mis				CCDS877.1,ENSG00000213281.4,N-ras,NM_002524.4,NP_002515,P01111
NSD2	Wolf-Hirschhorn syndrome candidate 1(MMSET)	7468.0	4:1892845-1982207	1		4p16.3	yes		MM			L	Dom	oncogene, fusion	T	IGH			CCDS33940.1,ENSG00000109685.17,KMT3G,MMSET,NM_133330.2,NP_579877,O96028,WHSC1
NSD3	Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3)	54904.0	8:38269697-38382272	1		8p11.23	yes		AML			L	Dom	oncogene, fusion	T, A	NUP98			CCDS43729.1,ENSG00000147548.16,FLJ20353,KMT3F,NM_023034.1,NP_075447,Q9BZ95,WHISTLE,WHSC1L1
NT5C2	5'-nucleotidase, cytosolic II	22978.0	10:103088018-103193306	1	Yes	10q24.33	yes		relapse ALL			L	Dom	oncogene	Mis		yes	Spastic paraplegia-45	CCDS7544.1,ENSG00000076685.18,GMP,NM_012229.4,NP_001127845,NP_036361,NP_001338098.1,NT5B,P49902,PNT5,SPG65,cN-II
NTRK1	neurotrophic tyrosine kinase, receptor, type 1	4914.0	1:156860894-156881642	1	Yes	1q23.1	yes		papillary thyroid, Spitzoid tumour			E	Dom	oncogene, TSG, fusion	T, A	TPM3, TPR, TFG, TP53, LMNA			CCDS1161.1,ENSG00000198400.11,MTC,NM_002529.3,NP_002520,P04629,TRK,TRKA
NTRK2	Neurotrophic Receptor Tyrosine Kinase 2	4915.0	9:84669778-85027070	1		9q21.33	yes		colorectal cancer, ganglioglioma, glioma, HNSCC, lung adenocarcinoma			E, O		oncogene, fusion	T, Mis	AFAP1, BCR, QK1, SQSTM1			CCDS6671.1,ENSG00000148053.15,Q16620,TRKB
NTRK3	neurotrophic tyrosine kinase, receptor, type 3	4916.0	15:87876757-88256731	1	Yes	15q25.3	yes		congenital fibrosarcoma, secretory breast			E, M	Dom	oncogene, fusion	T	ETV6			CCDS32322.1,ENSG00000140538.16,NM_001012338.2,NP_001012338,Q16288,TRKC
NUP98	nucleoporin 98kDa	4928.0	11:3675010-3797792	1		11p15.4	yes		AML			L	Dom	oncogene, fusion	T	HOXA9, NSD1, WHSC1L1, DDX10, TOP1, HOXD13, PRRX1, HOXA13, HOXD11, HOXA11, RAP1GDS1, HOXC11			CCDS7746.1,ENSG00000110713.15,NM_016320.4,NP_057404,NUP96,P52948
NUTM1	NUT midline carcinoma, family member 1	256646.0	15:34343315-34357728	1		15q14	yes		lethal midline carcinoma			E	Dom	oncogene, fusion	T	BRD3, BRD4			C15orf55,CCDS61585.1,DKFZp434O192,ENSG00000184507.15,FAM22H,NM_001284292.1,NP_001271221,NP_001271221.1,NUT,Q86Y26
OLIG2	oligodendrocyte lineage transcription factor 2 (BHLHB1)	10215.0	21:33025935-33029196	1		21q22.11	yes		T-ALL			L	Dom	oncogene, fusion	T	TRA			BHLHB1,CCDS13620.1,ENSG00000205927.4,OLIGO2,PRKCBP2,Q13516,RACK17,bHLHe19
P2RY8	purinergic receptor P2Y, G-protein coupled, 8	286530.0	X:1462572-1537107	1		Xp22.33	yes		B-ALL, Down syndrome associated ALL			L	Dom	oncogene, fusion	T	CRLF2			CCDS14115.1,ENSG00000182162.10,NM_178129.4,NP_835230,P2Y8,Q86VZ1
PABPC1	poly(A) binding protein cytoplasmic 1	26986.0	8:100702916-100722712	2		8q22.3	yes		HNSCC, biliary tract carcinoma			E		oncogene, TSG	Mis, F				CCDS6289.1,ENSG00000070756.15,NM_002568.3,NP_002559,P11940,PAB1,PABP1,PABPC2,PABPL1
PAX3	paired box gene 3	5077.0	2:222199888-222298981	1	Yes	2q36.1	yes		alveolar rhabdomyosarcoma			M	Dom	oncogene, fusion	T	FOXO1, NCOA1, NCOA2	yes	Waardenburg syndrome; craniofacial-deafness-hand syndrome	CCDS2448.1,ENSG00000135903.19,HUP2,NM_181459.3,NP_852124,P23760,WS1
PAX5	paired box gene 5 (B-cell lineage specific activator protein)	5079.0	9:36833275-37034185	1	Yes	9p13.2	yes		NHL, ALL, B-ALL			L	Dom	oncogene, TSG, fusion	T, Mis, D, F, S	IGH, ETV6, PML, FOXP1, ZNF521, ELN			BSAP,CCDS6607.1,ENSG00000196092.12,NM_016734.2,NP_057953,Q02548
PBX1	pre-B-cell leukemia transcription factor 1	5087.0	1:164559635-164851831	1	Yes	1q23.3	yes		pre B-ALL, myoepithelioma			L, M	Dom	oncogene, fusion	T	TCF3, EWSR1			CCDS1246.1,ENSG00000185630.18,NM_002585.3,NP_002576,NP_001340059.1,P40424
PDCD1LG2	programmed cell death 1 ligand 2	80380.0	9:5510570-5571254	1	Yes	9p24.1	yes		PMBL, Hodgkin lymphoma			L	Dom	oncogene, fusion	T	CIITA			B7-DC,Btdc,CCDS6465.1,CD273,ENSG00000197646.7,NM_025239.3,NP_079515,PD-L2,PDL2,Q9BQ51,bA574F11.2
PDGFB	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	5155.0	22:39223359-39244751	1		22q13.1	yes		DFSP			M	Dom	oncogene, fusion	T	COL1A1			CCDS13987.1,ENSG00000100311.16,NM_002608.3,NP_002599,P01127,SIS,SSV
PDGFRA	platelet-derived growth factor, alpha-receptor	5156.0	4:54229097-54298247	1	Yes	4q12	yes	yes	GIST, idiopathic hypereosinophilic syndrome, paediatric glioblastoma	GIST	familial gastrointestinal stromal tumour	L, M, O	Dom	oncogene, fusion	Mis, O, T	FIP1L1			CCDS3495.1,CD140a,ENSG00000134853.11,GAS9,NM_006206.4,NP_006197,NP_001334757.1,NP_001334759.1,NP_001334758.1,P16234,PDGFR2
PDGFRB	platelet-derived growth factor receptor, beta polypeptide	5159.0	5:150113837-150155860	1		5q32	yes		MPN, AML, CMML, CML			L	Dom	oncogene, fusion	T	ETV6, TRIP11, HIP1, RABEP1, H4, NIN, SPECC1, PDE4DIP			CCDS4303.1,CD140b,ENSG00000113721.13,JTK12,NM_002609.3,NP_002600,NP_001341945.1,P09619,PDGFR,PDGFR1
PIK3CA	phosphoinositide-3-kinase, catalytic, alpha polypeptide	5290.0	3:179148523-179240093	1	Yes	3q26.32	yes		colorectal, gastric, glioblastoma, breast			E, O	Dom	oncogene	Mis				CCDS43171.1,ENSG00000121879.4,NM_006218.3,NP_006209,P42336,PI3K
PIK3CB	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	5291.0	3:138652699-138759359	1	Yes	3q22.3	yes		SCC, NSCLC			E		oncogene	Mis				CCDS3104.1,ENSG00000051382.8,NM_006219.2,NP_006210,P42338,PIK3C1
PIM1	pim-1 oncogene	5292.0	6:37170203-37175426	1	Yes	6p21.2	yes		NHL			L	Dom	oncogene, fusion	T, Mis	BCL6			CCDS4830.1,ENSG00000137193.13,NM_002648.3,NP_002639,NP_001230115.1,P11309,PIM
PLAG1	pleiomorphic adenoma gene 1	5324.0	8:56160904-56211279	1		8q12.1	yes		salivary adenoma, lipoblastoma			E	Dom	oncogene, fusion	T	TCEA1, LIFR, CTNNB1, CHCHD7, COL1A2, HAS2			CCDS6165.1,ENSG00000181690.7,NM_002655.2,NP_002646,Q6DJT9,ZNF912
PLCG1	phospholipase C, gamma 1	5335.0	20:41136960-41175721	1	Yes	20q12	yes		angiosarcoma			E	Dom	oncogene, fusion	Mis				CCDS13313.1,ENSG00000124181.14,NCKAP3,NM_002660.2,NP_002651,P19174,PLC-II,PLC1,PLC148,PLCgamma1
POLQ	DNA polymerase theta	10721.0	3:121431431-121546006	1		3q13.33	yes	yes	oral SCC	breast cancer		E		oncogene, TSG	Mis				CCDS33833.1,ENSG00000051341.13,NM_199420.3,NP_955452,O75417,POLH
POU2AF1	POU domain, class 2, associating factor 1 (OBF1)	5450.0	11:111352252-111379692	1	Yes	11q23.1	yes		NHL			L	Dom	oncogene, fusion	T	BCL6			BOB1,CCDS31675.1,ENSG00000110777.11,NM_006235.2,NP_006226,OBF1,Q16633
POU5F1	POU domain, class 5, transcription factor 1	5460.0	6:31164337-31170693	1	Yes	6p21.33	yes		sarcoma			M	Dom	oncogene, fusion	T	EWSR1			CCDS34391.1,ENSG00000204531.17,MGC22487,NM_002701.5,NP_002692,OCT3,OTF3,Oct4,Q01860
PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	8493.0	17:60600183-60666280	1	Yes	17q23.2	yes		glioma, ovarian cancer, breast cancer			E	Dom	oncogene	A, Mis, N, F				CCDS11625.1,ENSG00000170836.11,NM_003620.3,NP_003611,O15297,PP2C-DELTA,Wip1
PRDM16	PR domain containing 16	63976.0	1:3069211-3438621	1	Yes	1p36.32	yes		MDS, AML			L	Dom	oncogene, fusion	T	MECOM			CCDS41236.2,ENSG00000142611.16,KIAA1675,KMT8F,MEL1,MGC166915,NM_022114.3,NP_071397,PFM13,Q9HAZ2
PREX2	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2	80243.0	8:67952118-68237030	1	Yes	8q13.2	yes		melanoma, pancreatic ductal adenocarcinoma			E	Dom	oncogene	Mis, N				CCDS6201.1,DEP.2,DEPDC2,ENSG00000046889.18,FLJ12987,NM_024870.3,NP_079146,P-REX2,PPP1R129,Q70Z35
PRKACA	protein kinase cAMP-activated catalytic subunit alpha	5566.0	19:14091688-14117744	1	Yes	19p13.12	yes		fibrolamellar hepatocellular carcinoma, cortisol secreting adrenal adenoma			E	Dom	oncogene	T, Mis, N	DNAJB1			CCDS12304.1,ENSG00000072062.13,NM_002730.3,NP_002721,NP_001291278.1,P17612,PKACa
PRKAR1A	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)	5573.0	17:68512379-68533423	1	Yes	17q24.2	yes	yes	papillary thyroid	myxoma, endocrine, papillary thyroid	Carney complex	E, M	Dom/Rec	oncogene, TSG, fusion	T, Mis, N, F, S	RET			CCDS11678.1,CNC1,ENSG00000108946.14,NM_212472.2,NP_997637,NP_002725,P10644,PRKAR1,TSE1
PSIP1	PC4 and SFRS1 interacting protein 1 (LEDGF)	11168.0	9:15464066-15511019	1	Yes	9p22.3	yes		AML			L	Dom	oncogene, fusion	T	NUP98			CCDS6479.1,DFS70,ENSG00000164985.14,LEDGF,NM_033222.4,NP_001121689,NP_150091,O75475,PSIP2,p52,p75
PTK6	protein tyrosine kinase 6	5753.0	20:63528001-63537354	1	Yes	20q13.33	yes		renal, gastric, head and neck, ovarian, others			E	Dom	oncogene, TSG	Mis, N				BRK,CCDS13524.1,ENSG00000101213.6,NM_005975.3,NP_005966,Q13882
PTPN11	protein tyrosine phosphatase, non-receptor type 11	5781.0	12:112419112-112504764	1	Yes	12q24.13	yes		JMML, AML, MDS			L	Dom	oncogene	Mis		yes	Noonan Syndrome	BPTP3,CCDS81741.1,ENSG00000179295.17,NS1,PTP2C,Q06124,SH-PTP2,SHP-2,SHP2
QKI	QKI, KH domain containing, RNA binding	9444.0	6:163414643-163578596	1	Yes	6q26	yes		angiocentric glioma, colorectal cancer			E, O	Dom	oncogene, TSG	Mis, F, T	MYB			CCDS5285.1,ENSG00000112531.16,NM_006775.2,NP_006766,Q96PU8,QK3
RAC1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	5879.0	7:6374539-6402520	1	Yes	7p22.1	yes		melanoma, carcinoma			E	Dom	oncogene	Mis, F				CCDS5349.1,ENSG00000136238.17,NM_018890.3,NP_061485,P63000,Rac-1,TC-25,p21-Rac1
RAD21	RAD21 homolog (S. pombe)	5885.0	8:116845935-116874866	1	Yes	8q24.11	yes		AML, endometrium, colorectal, lung			L, E	Rec	oncogene, TSG	Mis, N, F		yes	Cornelia de Lange syndrome-4	CCDS6321.1,ENSG00000164754.14,KIAA0078,NM_006265.2,NP_006256,O60216,SCC1,hHR21
RAF1	v-raf-1 murine leukemia viral oncogene homolog 1	5894.0	3:12583601-12664226	1	Yes	3p25.2	yes		pilocytic astrocytoma, prostate			O, E	Dom	oncogene, fusion	T, A	SRGAP3, ESRP1			CCDS2612.1,CRAF,ENSG00000132155.11,NM_002880.3,NP_002871,NP_001341619.1,P04049,Raf-1,c-Raf
RAP1B	Ras-Related Protein Rap-1b	5908.0	12:68610839-68671901	2		12q15	yes		glioma			O		oncogene	A, Mis				CCDS8984.1,DKFZp586H0723,ENSG00000127314.17,K-REV,P61224,RAL1B
RAP1GDS1	RAP1, GTP-GDP dissociation stimulator 1	5910.0	4:98261518-98442334	1	Yes	4q23	yes		T-ALL			L	Dom	oncogene, fusion	T	NUP98			CCDS47105.1,ENSG00000138698.14,NM_001100426.1,NP_001093896,P52306,SmgGDS
RARA	retinoic acid receptor, alpha	5914.0	17:40309194-40356796	1		17q21.2	yes		APL			L	Dom	oncogene, fusion	T	PML, ZBTB16, TRIM24, NUMA1, NPM1			CCDS11366.1,ENSG00000131759.17,NM_000964.3,NP_000955,NR1B1,P10276,RAR
RECQL4	RecQ protein-like 4	9401.0	8:144511291-144517826	1	Yes	8q24.3		yes		osteosarcoma, skin basal cell, skin sqamous cell	Rothmund-Thompson syndrome	M	Rec	oncogene, TSG	N, F, S				CCDS75804.1,ENSG00000160957.12,NM_004260.3,NP_004251,NP_004251.3,O94761,RecQ4
REL	v-rel reticuloendotheliosis viral oncogene homolog (avian)	5966.0	2:60881521-60931610	1		2p16.1	yes		Hodgkin lymphoma			L	Dom	oncogene	A				CCDS1864.1,ENSG00000162924.14,I-Rel,NM_002908.3,NP_002899,Q04864,c-Rel
RET	ret proto-oncogene	5979.0	10:43077027-43130351	1	Yes	10q11.21	yes	yes	medullary thyroid, papillary thyroid, pheochromocytoma, NSCLC, Spitzoid tumour	medullary thyroid,  papillary thyroid, pheochromocytoma	multiple endocrine neoplasia 2A/2B	E, O	Dom	oncogene, fusion	T, Mis, N, F	H4, PRKAR1A, NCOA4, PCM1, GOLGA5, TRIM33, KTN1, TRIM27, HOOK3, KIF5B, CCDC6	yes	Hirschsprung disease	CCDS7200.1,CDHF12,CDHR16,ENSG00000165731.18,HSCR1,MEN2A,MEN2B,MTC1,NM_020975.4,NP_066124,P07949,PTC,RET51
RHOA	ras homolog family member A	387.0	3:49359145-49412202	1	Yes	3p21.31	yes		diffuse gastric, T cell lymphomas, paediatric Burkitt lymphoma			E, L	Dom	oncogene, TSG	Mis, F, O				ARH12,ARHA,CCDS2795.1,ENSG00000067560.10,NM_001664.3,NP_001300870,NP_001655,NP_001300874.1,NP_001300873.1,P61586,RHOH12,Rho12,RhoA
ROS1	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)	6098.0	6:117288300-117425855	1	Yes	6q22.1	yes		glioblastoma, NSCLC, Spitzoid tumour, cholangiocarcinoma, borderline ovarian			O, E	Dom	oncogene, fusion	T	GOPC, SDC4, SLC34A2, EZR, LRIG3, HLA-A, MYO5A, PPFIBP1, ERC1, CLIP1, TPM3, ZCCHHC8, KIAA1598, PWWP2A			CCDS5116.1,ENSG00000047936.10,MCF3,NM_002944.2,NP_002935,P08922,ROS,c-ros-1
RSPO3	R-spondin 3	84870.0	6:127118604-127197296	1		6q22.33	yes		colorectal			E	Dom	oncogene, fusion	T	PTPRK			CCDS5135.1,ENSG00000146374.13,FLJ14440,NM_032784.4,NP_116173,Q9BXY4,THSD2
RUNX1	runt-related transcription factor 1  (AML1)	861.0	21:34787801-35049344	1		21q22.12	yes		AML, pre B-ALL, T-ALL			L	Dom	oncogene, TSG, fusion	T	RPL22, MECOM, CBFA2T3, RUNX1T1, ETV6, AFF3			AML1,AMLCR1,CBFA2,CCDS13639.1,ENSG00000159216.18,PEBP2A2,Q01196
RUNX1T1	runt-related transcription factor 1; translocated to, 1 (cyclin D-related)	862.0	8:91954967-92095654	1	Yes	8q21.3	yes		AML			L	Dom	oncogene, TSG, fusion	T	KMT2A, RUNX1			AML1T1,CBFA2T1,CCDS75766.1,CDR,ENSG00000079102.16,ETO,MTG8,NM_001198679.1,NP_001185608,ZMYND2
SALL4	spalt like transcription factor 4	57167.0	20:51782331-51802520	1	Yes	20q13.2	yes		colorectal cancer, breast cancer, prostate cancer, glioblastoma, melanoma			E		oncogene	Mis, F			Duane-radial ray syndrome	CCDS13438.1,ENSG00000101115.12,NM_020436.4,NP_065169,Q9UJQ4,ZNF797,dJ1112F19.1
SET	SET translocation	6418.0	9:128683655-128696400	1		9q34.11	yes		T-ALL			L	Dom	oncogene, fusion	T	NUP214			2PP2A,CCDS48037.1,ENSG00000119335.16,IGAAD,IPP2A2,NM_001122821.1,NP_001116293,PHAPII,Q01105,TAF-I,TAF-IBETA
SETBP1	SET binding protein 1	26040.0	18:44680898-45068510	1	Yes	18q12.3	yes	yes	aCML, sAML, MDS/MPN-U, CMML, JMML	neuroepithelial tumours	Schinzel-Giedion syndrome	L	Dom	oncogene, fusion	Mis, T	NUP98			CCDS11923.2,ENSG00000152217.17,KIAA0437,NM_015559.2,NP_056374,Q9Y6X0,SEB
SETDB1	SET domain bifurcated 1	9869.0	1:150926339-150964735	2		1q21.3	yes		malignant mesothelioma			E		oncogene	F, Mis				CCDS44217.1,ENSG00000143379.12,ESET,KG1T,KIAA0067,KMT1E,NM_001145415.1,NP_001138887,Q15047,TDRD21
SF3B1	splicing factor 3b, subunit 1, 155kDa	23451.0	2:197389784-197435091	1	Yes	2q33.1	yes		myelodysplastic syndrome			L	Dom	oncogene	Mis				CCDS33356.1,ENSG00000115524.15,Hsh155,NM_012433.3,NP_036565,O75533,PRPF10,Prp10,SAP155,SF3b155
SGK1	serum/glucocorticoid regulated kinase 1	6446.0	6:134169246-134318058	2		6q23.2	yes		Nodular lymphocyte predominant Hodgkin lymphoma			L		oncogene	Mis				CCDS47476.1,ENSG00000118515.11,NM_001143676.1,NP_001137148,O00141,SGK
SH3GL1	SH3-domain GRB2-like 1 (EEN)	6455.0	19:4360370-4400547	1		19p13.3	yes		AL			L	Dom	oncogene, fusion	T	KMT2A			CCDS32874.1,CNSA1,EEN,ENSG00000141985.9,MGC111371,NM_003025.3,NP_003016,Q99961,SH3D2B,SH3P8
SIX1	SIX homeobox 1	6495.0	14:60643415-60649462	1	Yes	14q23.1	yes		Wilms tumour			O		oncogene	Mis				CCDS9748.1,DFNA23,ENSG00000126778.9,Q15475
SIX2	SIX homeobox 2	10736.0	2:45005161-45009430	2		2p21	yes		Wilms tumour			O		oncogene	Mis				CCDS1822.1,ENSG00000170577.7,NM_016932.4,NP_058628,Q9NPC8
SKI	SKI proto-oncogene	6497.0	1:2228695-2310119	2		1p36.33	yes		melanoma			E		oncogene	Mis				CCDS39.1,ENSG00000157933.9,NM_003036.3,NP_003027,P12755
SMO	smoothened homolog (Drosophila)	6608.0	7:129188872-129213545	1	Yes	7q32.1	yes		skin basal cell			E	Dom	oncogene	Mis				CCDS5811.1,ENSG00000128602.9,FZD11,NM_005631.4,NP_005622,Q99835,SMOH
SND1	staphylococcal nuclease and tudor domain containing 1	27044.0	7:127652180-128092607	1		7q32.1	yes		pancreas acinar carcinoma			E	Dom	oncogene, fusion	T	BRAF			CCDS34747.1,ENSG00000197157.10,NM_014390.2,NP_055205,Q7KZF4,TDRD11,p100
SOX2	SRY (sex determining region Y)-box 2	6657.0	3:181711924-181714436	1		3q26.33	yes		NSCLC, oesophageal squamous carcinoma			E	Dom	oncogene	A		yes	Microphthalmia and oesophageal atresia syndrome	CCDS3239.1,ENSG00000181449.3,NM_003106.3,NP_003097,P48431
SRC	SRC proto-oncogene, non-receptor tyrosine kinase	6714.0	20:37346154-37406050	1	Yes	20q11.23	yes		colorectal cancer, endometrial carcinoma			E	Dom	oncogene	Mis, N				ASV,CCDS13294.1,ENSG00000197122.11,NP_005408.1,NP_938033.1,P12931,SRC1,c-src
SRSF2	serine/arginine-rich splicing factor 2	6427.0	17:76734115-76737333	1	Yes	17q25.1	yes		MDS, CLL			L	Dom	oncogene	Mis				CCDS11749.1,ENSG00000161547.16,NM_003016.4,NP_003007,PR264,Q01130,SC-35,SC35,SFRS2,SFRS2A
SRSF3	serine/arginine-rich splicing factor 3	6428.0	6:36594368-36605600	1		6p21.31	yes		follicular lymphoma			L	Dom	oncogene, fusion	T	BCL6			CCDS4823.1,ENSG00000112081.16,NM_003017.4,NP_003008,P84103,SFRS3,SRp20
SSX1	synovial sarcoma, X breakpoint 1	6756.0	X:48255317-48267444	1		Xp11.23	yes		synovial sarcoma			M	Dom	oncogene, fusion	T	SS18			CCDS14290.1,CT5.1,ENSG00000126752.7,NM_005635.3,NP_005626,NP_001265620,Q16384
SSX2	synovial sarcoma, X breakpoint 2	6757.0	X:52696896-52707161	1		Xp11.22	yes		synovial sarcoma			M	Dom	oncogene, fusion	T	SS18			CCDS14345.2,CT5.2a,ENSG00000241476.8,HD21,HOM-MEL-40,MGC119055,MGC15364,MGC3884,NM_003147.5,NP_003138,NP_001265626.1,Q16385,SSX
SSX4	synovial sarcoma, X breakpoint 4	6759.0	X:48383527-48393347	1		Xp11.23	yes		synovial sarcoma			M	Dom	oncogene, fusion	T	SS18			CCDS35240.1,CT5.4,ENSG00000268009.5,NM_005636.3,NP_005627,O60224
STAT3	signal transducer and activator of transcription 3 (acute-phase response factor)	6774.0	17:42313324-42388568	1	Yes	17q21.2	yes	yes	T-cell large granular lymphocytic leukaemia	paediatric large granular lymphocytic leukaemia		L	Dom	oncogene	Mis,O		yes	IPEX-like syndrome	APRF,CCDS32656.1,ENSG00000168610.14,NM_139276.2,NP_003141.2,NP_644805.1,P40763
STAT5B	signal transducer and activator of transcription 5B	6777.0	17:42199168-42276406	1	Yes	17q21.2	yes		large granular lymphocytic leukaemia, skin basal cell, APL			L, E	Dom	oncogene, TSG, fusion	Mis, O, T	RARA	yes	IPEX-like syndrome	CCDS11423.1,ENSG00000173757.9,NM_012448.3,NP_036580,P51692
STAT6	signal transducer and activator of transcription 6, interleukin-4 induced	6778.0	12:57095408-57111433	1		12q13.3	yes		solitary fibrous tumour, meningeal haemangiopericytoma			M, O	Dom	oncogene, fusion	T	NAB2			CCDS8931.1,D12S1644,ENSG00000166888.11,IL-4-STAT,NM_003153.4,NP_003144,NP_001171549,P42226
STIL	SCL/TAL1 interrupting locus	6491.0	1:47250142-47314140	1		1p33	yes		T-ALL			L	Dom	oncogene, fusion	T	TAL1			CCDS41329.1,ENSG00000123473.15,MCPH7,NM_001048166.1,NP_001041631,Q15468,SIL
SUZ12	suppressor of zeste 12 homolog (Drosophila)	23512.0	17:31937018-32001045	1	Yes	17q11.2	yes		endometrial stromal tumour			M	Dom	oncogene, TSG, fusion	T	JAZF1			CCDS11270.1,CHET9,ENSG00000178691.10,JJAZ1,KIAA0160,NM_015355.3,NP_056170,Q15022
SYK	spleen tyrosine kinase	6850.0	9:90801787-90898549	1		9q22.2	yes		MDS, peripheral T-cell lymphoma			L	Dom	oncogene, fusion	T	ETV6, ITK			CCDS6688.1,ENSG00000165025.14,NM_003177.6,NP_003168,P43405
TAF15	TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa	8148.0	17:35809455-35847242	1		17q12	yes		extraskeletal myxoid chondrosarcoma, ALL			L, M	Dom	oncogene, fusion	T	NR4A3, CHN1, ZNF384			CCDS32623.1,ENSG00000270647.5,NM_139215.2,NP_631961,Npl3,Q92804,RBP56,TAF2N,hTAFII68
TAL1	T-cell acute lymphocytic leukemia 1 (SCL)	6886.0	1:47216292-47229771	1		1p33	yes		lymphoblastic leukaemia/biphasic			L	Dom	oncogene, fusion	T	TRD, STIL			CCDS547.1,ENSG00000162367.11,NM_003189.5,NP_003180,NP_001277332,NP_001277334,P17542,SCL,TCL5,bHLHa17
TAL2	T-cell acute lymphocytic leukemia 2	6887.0	9:105662457-105663112	1		9q31.2	yes		T-ALL			L	Dom	oncogene, fusion	T	TRB			CCDS6767.1,ENSG00000186051.6,NM_005421.2,NP_005412,Q16559,bHLHa19
TBL1XR1	transducin (beta)-like 1 X-linked receptor 1	79718.0	3:177019355-177196478	1	Yes	3q26.32	yes		splenic marginal zone lymphoma, primary central nervous system lymphoma, colorectal carcinoma, gallbladder carcinoma			L, E, M	Rec	oncogene, TSG, fusion	F, Mis				C21,CCDS46961.1,DC42,ENSG00000177565.16,FLJ12894,IRA1,NM_001321195.1,NP_001308122,NP_001308124.1,Q9BZK7,TBLR1
TBX3	T-box 3	6926.0	12:114670255-114683590	1	Yes	12q24.21	yes		breast, large intestine, skin			E	Dom	oncogene, TSG	Mis, N, F, O		yes	ulnar-mammary syndrome	CCDS9176.1,ENSG00000135111.15,NM_016569.3,NP_057653,O15119,TBX3-ISO,UMS,XHL
TCF3	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	6929.0	19:1609290-1652329	1		19p13.3	yes		pre B-ALL			L	Dom	oncogene, TSG, fusion	T	PBX1, HLF, TFPT			CCDS12074.1,E2A,E47,ENSG00000071564.14,ITF1,MGC129647,MGC129648,NM_003200.3,NP_003191,NP_001338708.1,P15923,VDIR,bHLHb21,p75
TCF7L2	transcription factor 7-like 2	6934.0	10:112950407-113167493	1	Yes	10q25.3	yes		colorectal			E	Dom	oncogene, fusion	T	VTI1A			CCDS53577.1,ENSG00000148737.16,NM_001146274.1,NP_001139746,Q9NQB0,TCF-4,TCF4
TCL1A	T-cell leukemia/lymphoma 1A	8115.0	14:95709968-95714196	1	Yes	14q32.13	yes		T-CLL			L	Dom	oncogene, fusion	T	TRA			CCDS9941.1,ENSG00000100721.10,NM_021966.2,NP_068801,P56279,TCL1
TEC	tec protein tyrosine kinase	7006.0	4:48135783-48269864	2		4p12	yes		myxoid chondrosarcoma			M		oncogene, fusion	T				CCDS3481.1,ENSG00000135605.12,NM_003215.2,NP_003206,P42680,PSCTK4
TERT	telomerase reverse transcriptase	7015.0	5:1253167-1295047	1	Yes	5p15.33	yes	yes	melanoma, glioblastoma, hepatocellular carcinoma, bladder, skin basal cell, skin squamous cell, mesothelioma, medulloblastoma, other tumour types	melanoma		E, O	Dom	oncogene, TSG	Promoter Mis		yes	Dyskeratosis congenita, Telomere-related pulmonary fibrosis and/or bone marrow failure  1	CCDS3861.2,ENSG00000164362.18,EST2,NM_198253.2,NP_937983,O14746,TCS1,TP2,TRT,hEST2
TET1	tet methylcytosine dioxygenase 1	80312.0	10:68560656-68694482	1	Yes	10q21.3	yes		AML			L	Dom	oncogene, TSG, fusion	T	KMT2A			CCDS7281.1,CXXC6,ENSG00000138336.8,KIAA1676,LCX,NM_030625.2,NP_085128,Q8NFU7,bA119F7.1
TFE3	transcription factor binding to IGHM enhancer 3	7030.0	X:49028731-49043486	1	Yes	Xp11.23	yes		papillary renal, alveolar soft part sarcoma, renal			E	Dom	oncogene, fusion	T	SFPQ, ASPSCR1, PRCC, NONO, CLTC			CCDS14315.3,ENSG00000068323.16,NM_006521.5,NP_006512,NP_001269071.1,P19532,TFEA,bHLHe33
TFEB	transcription factor EB	7942.0	6:41683978-41736259	1		6p21.1	yes		renal cell carcinoma (childhood epithelioid)			E,M	Dom	oncogene, fusion	T	ALPHA			CCDS64425.1,ENSG00000112561.17,NM_001167827.2,NP_001161299,TCFEB,bHLHe35
TLX1	T-cell leukemia, homeobox 1 (HOX11)	3195.0	10:101130505-101137789	1		10q24.31	yes		T-ALL			L	Dom	oncogene, fusion	T	TRB, TRD			CCDS7510.1,ENSG00000107807.12,HOX11,NM_005521.3,NP_005512,P31314,TCL3
TLX3	T-cell leukemia, homeobox 3 (HOX11L2)	30012.0	5:171309284-171312134	1		5q35.1	yes		T-ALL			L	Dom	oncogene, fusion	T	BCL11B			CCDS34288.1,ENSG00000164438.5,HOX11L2,NM_021025.3,NP_066305,O43711,RNX
TMSB4X	Thymosin Beta 4 X-Linked	7114.0	X:12975110-12977226	2		Xp22.2	yes		DLBCL			L		oncogene	Mis, S, N, F				CCDS35202.1,ENSG00000205542.10,P62328,TB4X,TMSB4
TNC	tenascin C	3371.0	9:115020534-115118257	2		9q33.1	yes		SCC, melanoma			E		oncogene	Mis				CCDS6811.1,DFNA56,ENSG00000041982.15,HXB,MGC167029,NM_002160.3,NP_002151,P24821,TN
TNFRSF17	tumor necrosis factor receptor superfamily, member 17	608.0	16:11965107-11968068	1		16p13.13	yes		intestinal T-cell lymphoma			L	Dom	oncogene, fusion	T	IL2			BCM,BCMA,CCDS10552.1,CD269,ENSG00000048462.10,NM_001192.2,NP_001183,Q02223,TNFRSF13A
TP53	tumor protein p53	7157.0	17:7668402-7687538	1	Yes	17p13.1	yes	yes	breast, colorectal, lung, sarcoma, adrenocortical, glioma, Spitzoid tumour, multiple other tumour types	breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types	Li-Fraumeni syndrome	L, E, M, O	Rec	oncogene, TSG, fusion	Mis, N, F, T	NTRK1			CCDS11118.1,ENSG00000141510.16,LFS1,NM_001276761.1,NP_001119584,NP_000537,NP_001263689.1,NP_001263690.1,P04637,p53
TP63	tumor protein p63	8626.0	3:189631427-189897279	1	Yes	3q28	yes	yes	HNSCC, DLBCL	NSCLC		E		oncogene, TSG	Mis, N, T	TBL1XR1	yes	associated with Hay-Wells syndrome, ADULT syndrome, ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome (EEC), acro-dermato-ungual-lacrimal-tooth syndrome, limb mammary syndrome, Rapp-Hodgkin syndrome, split hand-split foot malformation	CCDS3293.1,EEC3,ENSG00000073282.12,KET,NBP,NM_003722.4,NP_003713,NP_001316893.1,NP_001316077.1,OFC8,Q9H3D4,SHFM4,TP53CP,TP53L,TP73L,p51,p53CP,p63,p73H,p73L
TRIM24	tripartite motif containing 24	8805.0	7:138460334-138589993	1		7q34	yes		APL			L	Dom	oncogene, TSG, fusion	T	RARA			CCDS5847.1,ENSG00000122779.17,NM_015905.2,NP_056989,O15164,RNF82,TIF1,TIF1A,Tif1a,hTIF1
TRIM27	tripartite motif-containing 27	5987.0	6:28903002-28923989	1		6p22.1	yes		papillary thyroid			E	Dom	oncogene, fusion	T	RET			CCDS4654.1,ENSG00000204713.10,NM_006510.4,NP_006501,P14373,RFP,RNF76
TRRAP	transformation/transcription domain-associated protein	8295.0	7:98878490-99013243	1		7q22.1	yes		melanoma			E	Dom	oncogene	Mis				CCDS59066.1,ENSG00000196367.13,NM_001244580.1,NP_001231509,PAF400,Q9Y4A5,TR-AP,Tra1
U2AF1	U2 small nuclear RNA auxiliary factor 1	7307.0	21:43092956-43107587	1		21q22.3	yes		CLL, MDS			L	Dom	oncogene	Mis				CCDS13694.1,ENSG00000160201.11,NM_006758.2,NP_006749,Q01081,RN,RNU2AF1,U2AF35,U2AFBP
UBR5	ubiquitin protein ligase E3 component n-recognin 5	51366.0	8:102253012-102412841	1	Yes	8q22.3	yes		mantle cell lymphoma, gastric, colorectal			L, E	Rec	oncogene	F, N, Mis, S				CCDS34933.1,DD5,EDD,EDD1,ENSG00000104517.12,HYD,KIAA0896,NM_015902.5,NP_056986,O95071
USP6	ubiquitin specific peptidase 6 (Tre-2 oncogene)	9098.0	17:5116438-5174991	1		17p13.2	yes		aneurysmal bone cyst			M	Dom	oncogene, fusion	T	COL1A1, CDH11, CNBP, OMD, THRAP3			CCDS11069.2,ENSG00000129204.16,HRP1,NM_001304284.1,NP_001291213,P35125,TRE17,TRESMCR,Tre-2,Tre2
USP8	ubiquitin specific peptidase 8	9101.0	15:50424382-50514419	1	Yes	15q21.2	yes		corticotroph adenoma			E	Dom	oncogene	Mis, N				CCDS10137.1,ENSG00000138592.13,HumORF8,KIAA0055,NM_001128610.2,NP_001122082,P40818,SPG59,UBPY
WAS	Wiskott-Aldrich syndrome	7454.0	X:48683779-48691427	1	Yes	Xp11.23		yes		lymphoma	Wiskott-Aldrich syndrome	L	Rec/X	oncogene	Mis, N, F, S				CCDS14303.1,ENSG00000015285.10,IMD2,NM_000377.2,NP_000368,P42768,THC,WASP,WASPA
WT1	Wilms tumour 1 gene	7490.0	11:32387775-32435630	1		11p13	yes	yes	Wilms tumour, desmoplastic small round cell tumour	Wilms tumour	Denys-Drash syndrome, Frasier syndrome, familial Wilms tumour	O	Rec	oncogene, TSG, fusion	D, Mis, N, F, S, T	EWSR1			AWT1,CCDS7878.2,ENSG00000184937.13,GUD,NM_024426.4,NPHS4,NP_077744,NP_077744.4,WAGR,WIT-2
WWTR1	WW domain containing transcription regulator 1	25937.0	3:149517235-149703273	1		3q25.1	yes		epithelioid haemangioendothelioma			M	Dom	oncogene, fusion	T	CAMTA1			CCDS3144.1,DKFZp586I1419,ENSG00000018408.14,NM_001348362.1,NP_001161750,NP_001335291.1,Q9GZV5,TAZ
XPO1	exportin 1 (CRM1 homolog, yeast)	7514.0	2:61477849-61538283	1	Yes	2p15	yes		CLL			L	Dom	oncogene	Mis				CCDS33205.1,CRM1,ENSG00000082898.16,NM_003400.3,NP_003391,O14980,emb
ZEB1	zinc finger E-box binding homeobox 1	6935.0	10:31319172-31529813	2		10p11.22	yes		CCRCC, melanoma			E		oncogene	Mis				AREB6,BZP,CCDS53505.1,ENSG00000148516.21,FECD6,NIL-2-A,NM_001323676.1,NP_001167567,NP_001310600.1,NP_001310605.1,NP_001310574.1,NP_001310601.1,NP_001310602.1,NP_001310579.1,NP_001310590.1,NP_001310571.1,NP_001310572.1,NP_001310575.1,P37275,PPCD3,TCF8,ZEB,Zfhep,Zfhx1a
ZNF521	zinc finger protein 521	25925.0	18:25061926-25352152	1		18q11.2	yes		ALL			L	Dom	oncogene, fusion	T	PAX5			CCDS32806.1,EHZF,ENSG00000198795.10,Evi3,NM_015461.2,NP_056276,Q96K83
